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Beclin 1 is a mammalian autophagy protein and has important functions in
development, tumor suppression and neurodegeneration. Beclin 1 exists in a protein
complex with Vps34, which is a class III phosphatidylinositol (PtdIns) 3-kinase and
mediates multiple vesicle trafficking pathways including autophagy and endocytosis.
However the precise role of Beclin 1 in autophagy regulation is not well understood and
information is lacking regarding the function of Beclin 1 in neuronal development and
degeneration. In a study that combines mouse genetics and biochemistry, three novel
Beclin 1 interaction proteins Atg14L (yeast Atg14-like), Rubicon (RUN domain and
cysteine-rich domain containing, Beclin 1-interacting protein) and Nrbf2 were identified
from mouse tissues. Gel filtration and co-immunoprecipitation show that these proteins
co-exist in one large in vivo protein complex, from which multiple sub-complexes may be
generated. Functional assays reveal that Atg14L positively regulates Vps34/PtdIns3K
kinase activity and autophagy while Rubicon shows negative regulatory effects.
Moreover, Beclin 1 and Atg14L synergistically promote autophagosome biogenesis while
over-expression of Rubicon causes formation of aberrant late endosomes/early lysosomes
and blocks autophagosome maturation. Therefore Atg14L and Rubicon regulate
autophagy in opposite directions and at different steps, possibly through forming
distinctive complexes with Beclin 1 and mediating Vps34/PtdIns3K kinase activity.
Meanwhile, to study the function of Beclin 1 in neuronal development and degeneration,

targeted deletion of beclin 1 was performed in pyramidal cells of the hippocampus and
the cerebral cortex and in cerebellar Purkinje cells. Consequently, the deletion leads to
rapid and severe degeneration in these cells. In degenerating pyramidal cells, there is
intracellular protein accumulation that may have resulted from impaired autophagy, and
activation of apoptotic pathway is also observed. In Purkinje cells, electron microscopy
studies show a large number of aberrant electron dense structures and they are closely
associated with intracellular membranes. Meanwhile, immuno-staining shows that
deletion of beclin 1 induces localization change of PtdIns(3)P, the product of
Vps34/PtdIns3K. Therefore it is suggested that Beclin 1 is critical for normal neuronal
development and that its deletion not only results in impaired autophagy but also may
induce abnormal membrane and vesicle trafficking, possibly due to disrupted regulation
of Vps34/PtdIns3K.
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Chapter I
Introduction

1.1 Autophagy
The balance between protein synthesis and degradation is important for normal
function and survival of cells. While the ubiquitin-proteasome pathway is responsible for
specific clearance of short-lived proteins, long-lived proteins are delivered to lysosomes
by autophagy, which is the major inducible pathway for general turnover of bulk
cytoplasmic components including entire organelles such as mitochondria (Klionsky and
Emr, 2000; Levine and Klionsky, 2004; Levine and Kroemer, 2008). There are three
types of autophagy: macroautophagy, microautophagy, and chaperone-mediated
autophagy. In microautophagy, cytosolic components are directly engulfed by lysosomal
limiting membrane at lysosome surface (Uttenweiler and Mayer, 2008), while in
chaperone-mediated autophagy, specific cytosolic proteins with certain motif structures
are degraded through chaperone complexes both in the cytocol and associated with
lysosomal membranes (Massey et al., 2006). Macroautophagy is the most widely studied
type of autophagy among these three types, and is usually referred to as autophagy. The
initial step of autophagy is the synthesis of de novo single membrane sac named isolation
membrane, which fuses at the edges and thereby enwraps cytosolic proteins and
organelles into a double-membrane structure called autophagosome. The outer membrane
of autophagosomes finally fuses with the membrane of lysosomes, releasing the inner
membrane and the content for hydrolytic enzyme mediated degradation in lysosomes.
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Although the morphology of autophagy has been widely studied in animal cells, the
molecular mechanism was poorly understood, until a screening experiment was
performed in the budding yeast Saccharomyces cerevisiae. In yeast, autophagy is induced
by nitrogen deprivation. The vacuoles generated in response to starvation, which are
equal to autophagosomes in mammalian cells, can be easily monitored by light
microscopy. From screening for mutant yeast cells in which autophagic vacuoles do not
accumulate under starvation conditions and as a result bulk protein degradation,
sporulation and cell viability are affected, fifteen autophagy-related (Atg) genes were
identified and later a few more were discovered (Tsukada and Ohsumi, 1993; Klionsky et
al., 2003). Almost all of these Atg genes have orthologs in higher eukaryotic cells such as
mammalian cells, suggesting that the machinery of autophagy is well conserved.

1.2 Two ubiquitin-like conjugation systems
Autophagy starts from autophagosome formation, and two ubiquitin-like
conjugation systems are important for this initial step. One is Atg5-Atg12 system
(Mizushima et al., 1998b). Atg12p forms a conjugate with Atg5p via a covalent bond
between the carboxy-terminal glysine of Atg12p and a lysine of Atg5p at residue 149.
This conjugation reaction is mediated by two other Atg proteins, Atg7p and Atg10p.
Apg7 shows significant homology to the ubiquitin activating enzyme (E1) (Tanida et al.,
1999), and Apg10p is considered to be a ubiquitin conjugating enzyme (E2)-like protein
(Nemoto et al., 2003). Finally, another protein, Atg16p, binds to the conjugated Atg5p
and oligomerizes to link a pair of Atg12p-Atg5p conjugates to form a complex
(Mizushima et al., 1999; Kuma et al., 2002). Similar conjugation was also found in
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human cells (Mizushima et al., 1998a) so it is highly conserved. In mammalian cells,
Apg5p-Apg12p conjugates localize on the isolation membrane and dissociate upon
autophagosome formation, therefore it is essential for the autophagosomal precursors to
form.
Another ubiquitin-like modification that is important for initiation of autophagy is
the processing of Atg8p, and in this process, Atg7p and Atg3p act as E1 and E2 like
enzymes respectively (Ichimura et al., 2000). Unlike Atg12p, Atg8p is finally conjugated
to phosphatidylethanolamine (PE), and it must first undergo a series of posttranslational
modification before it finally associates to the autophagosome membrane. A critical step
is a proteolytic cleavage of the C terminal of Apg8p, removing the arginine residue from
the nascent Atg8p precursor to expose a conserved glysine residue, and this step is
catalyzed by a constitutively expressed cysteine protease, Atg4p.
LC3 (microtubule-associated protein 1 (MAP1) light chain 3), the mammalian
orthologue of Atg8, is the first mammalian autophagy gene identified to be associated
specifically to the autophagosome membrane. Therefore, it can be used as a molecular
marker for the autophagic membrane (Kabeya et al., 2000). In vivo studies using a GFPLC3 tansgenic mouse reveal that under starvation conditions, increased numbers of
punctate dots are observed in most tissues, indicating the induction of autophagy
(Mizushima et al., 2004). Targeting of LC3 to the isolation membrane also requires Atg5Atg12 conjugate, as is shown by a study using Atg5-deficient mouse embryonic stem
cells (Mizushima et al., 2001).
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Two ubiquitin-like systems are required for autophagy. (a) The ubiquitin system. (b) The Atg12-Atg5
system. (c) The Atg8 system. (From Ohsumi Y, Nature Reviews Molecular Cell Biology, 2001)

1.3 Beclin 1
Another protein that is important for autophagy induction and yet has distinct
function from the two ubiquitin-like conjugation systems is Beclin 1. Beclin 1 is the
mammalian ortholog of yeast gene Atg6/Vps30, and is one of the first identified
mammalian orthologs of Atg genes.
In yeast, Atg6 is identical to Vps30, one of vacuolar protein sorting (VPS) genes
that are required for correct targeting of soluble hydrolases from late-Golgi to vacuoles
(Horazdovsky et al., 1995). Atg6p/Vps30p exists in two distinctive protein complexes
that both contain Vps34p, a phosphoinositide 3-kinase (PI3K), and its activator Vps15p.
One Atg6p/Vps30p complex contains Atg14p and is essential for autophagy induction,
and the other contains Vps38p and functions in vacuolar protein carboxypeptidase Y
(CPY) sorting pathway that delivers CPY and other vacuolar proteins from the late Golgi
to the vacuole (Kametaka et al., 1998; Kihara et al., 2001b). Atg14 mutants exhibit
defective autophagy but display normal CPY sorting, and the over production of Atg14p
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partially reverses the autophagy defect induced by Atg6/Vps30 mutation but has no effect
on CPY sorting defect (Kametaka et al., 1998). Meanwhile, Vps38 mutants exhibit
disrupted CPY sorting but intact autophagy levels. Moreover, Atg14p and Vps38p do not
co-immunoprecipitate. Therefore, the Atg14p containing and Vps38p containing
Atg6p/Vps30p-Vps34p-Vps15p complexes are two distinctive complexes and function
separately, and Atg6p/Vps30p is unique and different from other Atg proteins in that it is
not required for autophagy alone. Given the fact that loss of Atg38 dramatically disruptes
interaction between Atg6p/Vps30p and Vps34p-Vps15p while deletion of Atg14 has little
effect, it is estimated that Vps38p containing complex is much more abundant in yeast
cells (Kihara et al., 2001b).

Model for two distinct Atg6p/Vps30p-Vps34p-Vps15p complexes (from Kihara et al., 2001)

In yeast, several autophagy proteins, including Atg5p, Atg16p and Atg8p that
reside on autophagosome membrane, and Atg1p, a kinase functioning in autophagosome
formation, are all localized on perivacuolar structures prior to autophagosome formation.
5

These structures were named pre-autophagosomal structures (PASs) and both
Atg6/Vps30p and Atg14p are important for delivering other Atg proteins from cytosol to
PASs (Kihara et al., 2001b; Suzuki et al., 2001).
In mammalian cells Beclin 1 was first identified as a novel coiled-coil protein that
interacts with cell death inhibitor Bcl-2 through a yeast two-hybrid screen using an adult
mouse brain library. From deletion mutation analysis it is estimated that the putative Bcl2 binding domain is localized at the N-terminus of the protein, while the BH1 domain in
Bcl-2 is responsible for its interaction with Beclin 1 (Liang et al., 1998). Recently Beclin
1 was further shown to be a Bcl-2-homology-3 (BH3)-only protein (Maiuri et al., 2007;
Oberstein et al., 2007). Beclin 1 is mono-allelically deleted in a high percentage of
human breast, ovarian and prostate carcinomas (Aita et al., 1999), and its gene transfer
inhibits cell growth in human breast cancer cell line as well as tumorigenesis in nude
mice (Liang et al., 1999). Therefore Beclin 1 is considered a haploinsufficient tumor
suppressor gene in mammals. Moreover, homozygous targeted disruption of beclin1 in
mice caused the mice to die between embryonic day 7.5 (E7.5) and E8.5, indicating that
Beclin 1 is important for embryonic development, and heterozygous disruption results in
increased spontaneous tumorigenesis (Qu et al., 2003; Yue et al., 2003).
Like yeast Atg6p/Vps30p, Beclin 1 also mediates autophagy in mammalian cells.
Transformation of beclin 1 into Atg6/Vps30-disrupted yeast restored the autophagy to
normal levels, and transfer of beclin 1 gene into MCF7 human breast carcinoma cells that
do not express detectable levels of endogenous Beclin 1 increased the autophagy levels
after serum and amino-acid deprivation (Liang et al., 1999). Beclin 1-/- ES cells show
defect in nutrient deprivation induced autophagy but no significant changes in apoptosis
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(Yue et al., 2003), and Beclin 1+/- mice show reduced autophagy levels in tissues (Qu et
al., 2003; Yue et al., 2003). Therefore the function of Atg6p/Beclin 1 in autophagy is well
conserved.

1.4 Vps34/PtdIns3K and its function in regulation of autophagy
In mammalian cells, quantitative analyses show that Beclin 1 localizes both in
cytosol and on membranes, and that all Beclin 1 is associated with Vps34/PtdIns3K, a
type III phosphoinositide 3 (PI 3)-kinase that generates phosphotidylinositol 3-phosphate
(PtdIns(3)P) from the substrate phosphatidylinositol (PI) (Schu et al., 1993; Kihara et al.,
2001a). The Beclin 1-Vps34/PtdIns3K complex localizes to the trans-Golgi network
(TGN) , and Vps34/PtdIns3K is recruited from the cytosol to the membrane and is
activated by its activator Vps15p, which is a membrane associated serine/threonine
protein kinase that helps activate the PI 3-kinase activity of Vps34/PtdIns3K (Stack et al.,
1993; Stack et al., 1995).
Vps34/PtdIns3K functions in multiple vesicle trafficking pathways including
endocytosis and is also essential for autophagy induction (Simonsen et al., 2001; Lindmo
and Stenmark, 2006). Deletion of Vps34p in yeast disrupts starvation induced autophagy
(Kihara et al., 2001b), and in HT-29 human colon cancer cells treatment with PI 3-kinase
inhibitors wortmannin, LY294002 or 3-methyladenie (3-MA), as well as down-regulation
of Vps34/PtdIns3K, inhibits autophagy. In contrast, adding Vps34/PtdIns3K product
PtdIns(3)P to the cells promotes autophagy (Petiot et al., 2000). Among the PI 3-kinase
inhibitors, 3-MA preferentially inhibits class III PI 3-kinases and is widely used as an
inhibitor of autophagy.
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Like in yeast, the function of Beclin 1-Vps34/PtdIns3K complex in the regulation
of autophagy is likely to be at the initial step of autophagy induction. With Beclin 1,
Vps34/PtdIns3K participates in the nucleation of autophagosome formation, and also
mediates localization of other autophagy proteins to the preautophagosomal structure
(PAS) (Kihara et al., 2001b; Suzuki et al., 2001). The dynamic membrane trafficking
mediated by Vps34/PtdIns3K complex is important for autophagy induction.
The Vps34/PtdIns3K product PtdIns(3)P has several known protein effectors that
have specific domains. The first identified PtdIns(3)P binding domain is FYVE (for
conserved in Fab1, YOTB, Vac1 and EEA1) zinc finger domain (Stenmark et al., 2002),
and another one is conserved Phox-homology (PX) domain (Ellson et al., 2002). From
their specific binding to PtdIns(3)P, these domains can be used as probes to study the
localization of PtdIns(3)P.
Although Beclin 1 is essential for regulatory function of Vps34/PtdIns3K on
autophagy it is not necessary for the other function of Vps34/PtdIns3K on protein
trafficking. Forced expression of beclin 1 in yeast strains that are deficient in Atg6/Vps30
does not rescue the disrupted CPY sorting pathway (Liang et al., 1999). Furthermore,
knockdown of Beclin 1 in mammalian cells does not affect the lysosomal enzyme sorting
and protein trafficking in the endocytic pathway (Zeng et al., 2006).

1.5 Pro-survival or pro-death?
It has long been debated what the function of autophagy is in cell death, and in
yeast it is considered that autophagy generally functions in favor of cell survival under
stressful conditions such as starvation. Yeast with Atg gene mutations fail to initiate
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autophagy and die under starvation conditions (Tsukada and Ohsumi, 1993; Klionsky et
al., 2003). Evidence supports that this is also true in other species because in autophagy,
cytoplasm components are degraded to generate an internal reserve of nutrients, and
amino acids from lysosomal degradation can be used as energy source and for novel
protein synthesis.
In the nematode Caenorhabditis elegans, in order to survive unfavorable
environment such as food limitation or increased temperature, C elegans enter dauer, a
stage of developmental arrest. Animals that carry a loss of function mutation in insulinlike tyrosine kinase receptor daf-2 show constitutive entry into dauer at 25°C and
extended adult life-span at lower temperatures. When the expression of bec-1, the C.
elegans ortholog of Atg6/Vps30, was inhibited with RNA interference (RNAi), animals
showed abnormal dauer morphogenesis and died within a few days at 25°C. Treatment
with bec-1 RNAi also reduced the extension of life-span of daf-2 mutant animals. RNAi
treatment targeting other autophagy genes induced similar phenotypes, indicating that
autophagy genes are important for dauer morphogenesis and life-span extension in C.
elegans (Melendez et al., 2003). In the fruitfly Drosophila melanogaster, the fat body
formed during the larval period functions as a sensor for nutritional levels. Starvation
induces a significant increase in the level of autophagy in the fat body, and either larva
ubiquitous or fat body targeted inhibition of autophagy with RNAi against Drosophila
ortholog of Atg5 resulted in reduced larva or cell size (Rusten et al., 2004; Scott et al.,
2004). In mammalian cells, when primary cells or immortalized interleukin-3 (IL-3)
dependent cells generated from the bone marrow of Bax/Bak double knockout mice (in
which deletion of the two pro-apoptotic members of the Bcl-2 family makes the cells
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resistance to apoptosis) are deprived of IL-3, cells are not able to utilize the nutrients in
the extracellular media and activate autophagy to degrade intracellular contents for ATP
production and survival maintenance. Treatment of IL-3 deprived cells with either small
hairpin RNA (shRNA) against autophagy gene Atg5 or Atg7, or with an autophagy
inhibitor, induces cell death. This can be reversed by supplying the cells with alternative
metabolic substrate for oxidative phosphorylation at mitochondria to make up for the loss
of autophagy. This indicates that in the situation of growth factor withdraw autophagy
functions to maintain cell survival (Lum et al., 2005). Furthermore, the autophagy level
in mice is low during embryogenesis but is transiently activated after birth to maintain
adequate amino acid levels so as to combat the nutrient limitation that neonates face.
Mice deficient in either Atg5 or Atg7 are defective in autophagy and die within one day
after delivery, showing reduced amino acid levels in tissues and signs of energy depletion.
This suggests that autophagy in essential for mammalian survival during neonatal
starvation (Kuma et al., 2004; Komatsu et al., 2005). In conclusion, from yeast to
mammalian cells conserved autophagy is induced to maintain cell and animal survival in
stressful conditions such as starvation.
In some other cases, autophagy constitutes a pathway that contributes to cell death,
possibly through excessive self-digestion. This pathway is called autophagic cell death or
type II programmed cell death, in contrast to apoptosis or type I programmed cell death.
In a number of mammalian cell lines, treatment with the caspase inhibitor (O-methyl)fluoro-methylketone (zVAD) induces non-apoptotic cell death that shows characteristics
of autophagy, and the cell death can be blocked with either the autophagy inhibitor 3-MA
or wortmannin, or by knockdown of autophagy gene Atg7 or beclin 1 (Yu et al., 2004).
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Moreover in Bax-/-/Bak-/- mouse embryonic fibroblast cells, apoptotic death stimulation
induces non-apoptotic cell death that exhibits autophagy induction, and this cell death can
be suppressed with autophagy inhibitor treatment. It is also dependent on autophagy
proteins Atg5 and Beclin 1 (Shimizu et al., 2004). In addition, in human cervical
carcinoma Hela cells, Atg5 interacts with Fas-associated protein with death domain
(FADD) to contribute to autophagic cell death,

which can be inhibited with Atg5

knockdown or 3-MA treatment (Pyo et al., 2005). Therefore autophagy may function in
both directions, to maintain cell survival and to mediate cell death, depending on the
context.

1.6 The complex role of Beclin 1 in autophagy and apoptosis
As the possible contributing force to type II programmed cell death, autophagy
has complex crosstalk with type I programmed cell death (apoptosis), and one intriguing
function of Beclin 1 is its coordination of autophagy and apoptosis. Beclin 1 was first
identified as interaction protein of Bcl-2, and it contains a BH3 domain that is both
necessary and sufficient for its interaction with Bcl-XL, both of which are members of the
Bcl-2 family that have pro-survival functions in the apoptotic pathway (Maiuri et al.,
2007; Oberstein et al., 2007). The interaction between Beclin 1 and Bcl-2 may occur on
outer membranes of mitochondria or endoplasmic reticulum (ER), and forced expression
of ER-targeted Bcl-2 inhibits binding of Beclin 1 to Vps34/PtdIns3K as well as Beclin 1
dependent autophagy while Beclin 1 mutants that cannot bind to Bcl-2 induce excess
level of autophagy (Pattingre et al., 2005). Meanwhile, treatment of cells with BH3mimetic compound ABT737, which inhibits the Beclin 1-Bcl-2/ Bcl-XL interaction in a
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competitive manner, stimulates Beclin 1-dependent autophagy (Maiuri et al., 2007).
Furthermore, Bcl-2 down-regulation in human leukemic HL60 cells with expression of
antisense message induces massive cell death accompanied with activated autophagy
(Saeki et al., 2000). Therefore, Bcl-2 and other apoptotic proteins have regulatory effect
on autophagy and this occurs through interaction with Beclin 1.
Change in autophagy levels can also affect apoptosis. In fact inhibition of
autophagy often leads to activation of apoptosis. In C elegans, the Beclin 1 ortholog
BEC-1 forms a complex with Bcl-2 ortholog CED-9, and disruption of bec-1 induced
apoptosis (Takacs-Vellai et al., 2005). In nutrient depleted mammalian cells, inhibition of
autophagy either with siRNA targeting critical Atg genes including beclin 1 or with
chemical autophagy inhibitors often leads to cell death that is dependent on mitochondrial
outer membrane permeabilization and caspase activation and is therefore apoptotic (Boya
et al., 2005). Similarly, inactivation of LAMP2 by RNAi inhibits fusion of
autophagosomes with lysosomes, and induces accumulation of autophagosomes under
starvation that is followed by cell death with features of apoptosis (Gonzalez-Polo et al.,
2005).
Reagents that inhibit apoptosis can also induce autophagy. Treatment of HL-60
human myeloid leukemian cells with vitamin D3 inhibits apoptosis but induces
autophagy, possibly through up-regulation of Beclin 1 and Vps34/PtdIns3K protein levels
(Wang et al., 2008).
In summary, in response to various stimuli, autophagy and apoptosis are
selectively induced in cells, and altering one pathway often leads to changes in the other.
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Beclin 1 may be the key protein in coordinating the two pathways through forming
different protein complexes with different interaction partners.

The relationship between apoptosis and autophagy (From Maiuri M et al., Nature Reviews Molecular
Cell Biology, 2007)

1.7 Beclin 1 interacting proteins
In addition to Bcl-2 and Vps34/PtdIns3K, recently several novel Beclin 1
interaction proteins have been identified. UV irradiation resistance-associated gene
(UVRAG) was identified as a protein that immunoprecipitated with Bcl-2-Beclin 1Vps34/PtdIns3K multiprotein complex. It binds directly to Beclin 1 through the coiledcoil domains in itself and in Beclin 1, and they interdependently promote autophagy and
induce

autophasosome

formation,

possibly

thorough

positive

regulation

of

Vps34/PtdIns3K lipid kinase activity by UVRAG. Like beclin 1, UVRAG is also
monoallelically deleted in various human cancers, and ectopic expression of UVRAG in
one type of these cells (human colon cancer HCT116 cells) suppresses cell proliferation
and inhibits tumorigenicity of the cells (Liang et al., 2006). Bif 1, originally discovered as
a Bax-binding protein that localizes on intracellular membranes, was shown to form a
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complex with Beclin 1. This interaction is thought to be bridged by UVRAG, through
binding between the C-terminal SH3 domain of Bif1 and UVRAG, and like UVRAG,
Bif-1 also positively regulates Vps34/PtdIns3K lipid kinase activity and autophagy
(Takahashi et al., 2007). Ambra1 (activating molecule in Beclin 1-regulated autophagy) is
a gene involved in nervous system development that was isolated from a large-scale
mutagenesis approach. Homozygous disruption of Ambra1 induces neural tube defects,
unbalance cell proliferation and excessive apoptosis. Yeast two-hybrid screening with a
portion of Ambra1 identified Beclin 1, suggesting that Ambra1 is also a Beclin 1
interaction protein, and Ambra1 o positively regulates autophagy. Consistent with this
function, Ambra1 deficient embryos show severe defect in autophagy and accumulation
of ubiquitinated proteins (Fimia et al., 2007).
However, despite the recent discoveries, the exact role of Beclin 1 in autophagy
regulation and its autophagy unrelated functions still remain to be characterized.
Although yeast Atg6/Vps30p forms two distinctive complexes that have different
functions, it is not known how many Beclin 1-containing protein complexes mammalian
cells possess and the composition of the complex(es). Furthermore the molecular
mechanism underlying the function of Beclin 1 in autophagy regulation still remains
unknown. Unlike atg5-/- and atg7-/- mice that are born almost normally and then die
within one day, beclin 1-/- mice die as early as on embryonic day 7.5 and show excessive
developmental defect. Moreover, neither tumorigenesis nor abnormal cell proliferation
was observed in atg5 or atg7 (homozygous or heterozygous) deficient mice. These results
suggest that Beclin 1 may have a more important function in embyogenesis and tumor
suppression and this function may or may not be related to autophagy.
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1.8 Beclin 1 and autophagy in neuronal development and diseases
Although the pathways of autophagy are well characterized in yeast and its
function widely studied in many tissues of mammalian animals, its exact function in the
nervous system is not well understood. Its morphological features such as excessive
double membrane autophagosome formation and high electron density lysosomes have
been reported in many human neurodegenerative diseases such as transmissible
spongiform encephalopathies, Polyglutamine diseases, Alzheimer’s disease (AD) and
Parkinson’s disease (PD) (Williams et al., 2006; Rubinsztein et al., 2007). However it is
still in debate whether autophagy is one of the cell death executing forces in
neurodegenerative diseases, whether it is a failed attempt at protection, or just a
secondary effect. Many in vivo studies in disease model mice and in vitro studies using
cultured primary neurons have suggested that autophagy is a self protective response to
the stress that is induced by accumulation of toxic proteins in many neurodegenerative
diseases (Larsen and Sulzer, 2002).
Consistent with this possible protective function, beclin 1 expression level has
been shown to decrease in human brains in an age-dependent manner, and Beclin 1
mediated autophagy reduces intracellular Huntingtin accumulation (Shibata et al., 2006).
Meanwhile, Beclin 1 levels are reduced in cortical gray matter from AD patients, and
heterozygous deletion of beclin 1 in a mouse model for AD increased the amyloid
accumulation in neurons as well as extracellular deposit (Pickford et al.,
2008).

In addition, after closed head injury, Beclin 1 levels increases quickly and

dramatically in both neurons and surrounding astrocytes at the injury site, suggesting that
Beclin 1 is involved in brain response to head trauma (Diskin et al., 2005). Up-regulation
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of Beclin 1 level and activation of autophagy are also observed in Niemann-Pick type C
disease, one type of inherited sphingolipid storage diseases that cause neurodegeration
and cognitive impairment (Pacheco et al., 2007).
Induction of autophagy is also observed in non-apoptotic Purkinje cell death in
Lurcher (Lc) mice, an extensively used model of Purkinje cell degeneration. Purkinje
cells are specifically lost in various neurodegenerative conditions such as spinalcerebellar
ataxia, ataxia telangectasia, autism and certain prion encephalopathies, but the molecular
mechanism underlying Purkinje cell death is poorly understood. Lurcher is a
spontaneous, semidominant mouse neurological mutation. A point mutation in Purkinje
cell specific glutamate receptor changes the receptor to a constitutive active form, and
excessive influx of calcium induces cell-autonomous death of cerebellar Purkinje cells
(Zuo et al., 1997). Degenerating Purkinje cells exhibit elevated levels of autophagy, and
yeast two-hybrid study using C terminal cytosolic tail of glutamate receptor as a bait
identified Beclin 1, suggesting that Beclin1 mediated autophagy may be related to
Lurcher Purkinje cell degeneration (Yue et al., 2002).
Autophagy may be a quick response by the brain to protect itself in response to
injury or accumulation of toxic protein aggregates. Furthermore, the basal level of
autophagy is important in maintaining the normal function of the brain, since inhibition
of basal autophagy in the brain has been shown to induce neurodegeneration.. When Atg5
or Atg7 expression is specifically deleted in the central nervous system, cytosolic proteins
in neurons accumulate, and ultimately become inclusion bodies that are ubiquitin
positive, and activated apoptosis and neurodegeneration were observed. This suggests
that basal level of autophagy is essential for maintaining normal functions of neurons by
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clearing cytosolic proteins and preventing them from forming aggregates (Hara et al.,
2006; Komatsu et al., 2006).
In addition to its critical function in mediating cell survival and cell death,
autophagy is also important in cellular and tissue development and remodeling, through
turnover and recycling of organelles and proteins. Unc51, which is a C. elegans ortholog
of Atg1, is important for axonal elongation (Ogura et al., 1994), while Drosophila
ortholog of Apg4 was identified as modifier of Notch signaling pathway, and its loss of
function affected wing development (Thumm and Kadowaki, 2001). From its
involvement in recycling of proteins and membranes, it can be hypothesized that
autophagy may also be related to dynamic morphological changes of neuronal and
synaptic structures, and that it may be involved in plasticity in the central nervous system.

1.9 Summary
As an essential protein for autophagy induction, Beclin 1 is part of the
Vps34/PtdIns3K complex and functions at the initial step of autophagosome formation.
Moreover, through its organelle specific binding with Bcl-2, Beclin 1 is also important in
mediating cross talk between autophagy and apoptosis. Although it has been shown in
yeast that Atg6p forms two distinctive complexes with different functions, and recently
several novel Beclin 1 interaction proteins have been identified in mammalian cells, the
exact nature of Beclin 1 complex(es) is unclear. Information regarding the function of
Beclin 1 on neuronal development is still lacking. Therefore in this study, we combined
genetic and biochemical approaches to study the formation of Beclin 1 complex(es) in
mammalian cells and the function of Beclin 1 in the central nervous system.
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Chapter II
Identification and Characterization of Beclin 1 Interaction Proteins

2.1 Generation of beclin 1-EGFP transgenic mice
Beclin 1-EGFP transgenic mice were generated using bacterial artificial
chromosome (BAC) techniques. As a result of homologous recombination through BAC
modification, EGFP-coding cDNA was inserted immediately in front of the stop codon of
beclin 1 gene inside the BAC, and CsCl purified BAC DNA was pro-nuclear injected to
generate transgenic mice (Fig. 1a). Positive mice that have EGFP integrated into the
genome were identified with PCR and further confirmed with southern blot (data not
shown). Two founder mice were obtained from injection, and both gave germ line
transmission. Expression of Beclin 1-EGFP protein was confirmed with western blot
using brain tissue homogenate. Using Beclin 1 antibody, it was observed that one line had
higher expression level of Beclin 1-EGFP fusion protein than the other and the level was
comparable to that of endogenous Beclin 1 protein (data not shown). This line was used
for further study. Immuno-fluorescence studies on tissue sections using anti-GFP
antibody confirmed that Beclin 1-GFP fusion protein was localized diffusely in the
cytoplasm, which is consistent with the reported localization of the endogenous Beclin 1
protein (Arsov et al., 2008).

2.2 Generation of beclin 1-/-; beclin 1-EGFP rescued mice
Since beclin 1 homozygous deletion is embryonic lethal, it was tested whether Beclin 1EGFP fusion protein could restore the Beclin 1 protein function and rescue the embryonic
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Figure 1-1. Beclin 1-EGFP transgene rescued the embryonic lethality of beclin 1
homozygous deletion (beclin 1 -/-)
(a) Schematic representation of EGFP insertion in BAC-mediated Beclin 1-EGFP
transgenics.
(b) Breeding strategy for generating mice in which beclin 1-EGFP transgene replaces the
endogenous beclin 1 alleles. Beclin 1-EGFP mice were crossed with beclin 1

+/-

mice to

generate “rescued mice” (beclin 1 -/-; beclin 1-EGFP).
(c) Western blot analysis confirmed the replacement of endogenous Beclin 1 with Beclin
1-EGFP in beclin 1 -/-; beclin 1-EGFP mice, as detected by anti-Beclin 1 antibody.
(d) Theoretical distribution (Mendeline ratio) of each mouse genotype in the breeding
experiments. In the breeding to generate rescued mice, the theoretical ratio of the rescued
mice to the whole litter is 1/7. In this study, 11 out of a total of 69 mice (from 8 litters)
were the beclin 1 -/-; beclin 1-EGFP genotype (chi square test with the value 0.22, p>0.6,
df=1). In the second round breeding with the rescued mice, the theoretical ratio of the
rescued mice born to the whole litter is 1/3, and 12 out of 36 mice (from 6 litters) were of
that genotype. Therefore Beclin 1-EGFP completely rescued the early embryonic
lethality in beclin 1

-/-

mice, and thus can functionally substitute for the endogenous

Beclin 1 protein.
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lethal phenotype. Beclin 1-EGFP transgenic mice were first crossed with beclin 1 +/- mice
to generate beclin 1+/-; beclin 1-EGFP mice, and these mice were further crossed with
beclin 1+/- mice (Fig. 1b). Tail clips were cut and protein was extracted for western blot
with anti-Beclin 1 antibody. Beclin 1-/-; beclin 1-EGFP mice were identified as having
only Beclin 1-EGFP fusion protein but no endogenous Beclin 1 protein (Fig. 1c).
Rescued mice showed a similar life span to control mice, and did not show significant
phenotypic abnormality (data not shown). Mating was repeated and in total 69 mice were
born from 8 mating pairs, and among them 11 mice were confirmed to be rescued mice.
The ratio of rescued mice to total litter size was close to 1:7, which is the predicted
number if Mandel’s law is followed (chi-square test with the value 0.22, p>0.6, df=1, Fig.
1d). Rescued mice were further crossed with beclin 1+/- mice to test if they can reproduce
normally. Within totally 36 mice born from 6 breeding pairs, 12 mice were rescued mice,
and the ratio again followed the 1:3 predicted by Mandel’s law (Fig. 1d). Therefore it can
be concluded that over-expression of Beclin 1-EGFP fusion protein completely rescued
embryonic lethal phenotype of beclin 1 homozygous deletion, and that the Beclin 1EGFP fusion protein possesses the physiological function of the endogenous Beclin 1
protein.

2.3 Identification of Beclin 1 interaction proteins
Rescued mice were used for identification of Beclin 1 interaction proteins so that
no endogenous Beclin 1 protein would compete for binding. Whole brains, livers and
thymuses were dissected out from rescued mice and littermate control mice, and
homogenate was prepared. After immunoprecipitation was performed using anti-GFP
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Figure 1-2. Identification of novel Beclin 1-interaction proteins from beclin 1 -/-;
beclin 1-EGFP mice
(a) Coomassie-stained SDS-PAGE gel revealed the Beclin 1-interacting proteins
immuno-isolated from the brain and liver tissues of the “rescued” mice by using anti-GFP
antibody (Lane 2 and 4). Protein bands in the gel were isolated and identified by mass
spectrometric analysis as Vps15/p150 (band 1), Vps34/ PtdIns3K (band 3), UVRAG
(band 4), Beclin 1-EGFP (band 5), Nrbf2 (band 7, asterisk) and two novel proteins
Atg14L (band 6, asterisk, gi|27369860) and Rubicon (band 2, asterisk, gi|45708948). The
control mice were the beclin 1 +/– littermates (P16) (Lane 1 and 3).
(b) Schematic diagrams of the domain structures of Atg14L, Rubicon and Nrbf2. Atg14L
contains two coiled-coil domains (CCD1 and CCD2), which are also homologous to
SMC domain (Structural Maintenance of Chromosomes). Rubicon contains an Nterminal RUN (for RPIP8, UNC-14 and NESCA) domain, a C-terminal cysteine-rich
domain, and a CCD domain in the central of the protein sequence. Nrbf2 contains a
coiled-coil domain in the central part of the protein.
(c and d) HEK 293T cells were transiently transfected with either N-terminal FLAGtagged

(d)

or

C-terminal

EGFP-tagged

(e)

Atg14L,

Nrbf2

and

Rubicon.

Immunoprecipitation was performed with anti-FLAG (d) or anti-GFP antibody (e). The
endogenous Beclin 1 co-immunoprecipitated was detected by western blot analysis using
anti-Beclin 1 antibody. WCL: whole cell lysate; IP: immunoprecipitated.
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antibody, proteins were separated in SDS-PAGE gel, followed by visualization with
coomassie blue staining. Distinct bands that were only observed from rescued mice but
not from control mice were cut out and proteins were identified with mass spectrometry.
From rescued mouse tissues, at least seven bands were identified that were not seen from
control tissues. In addition to Beclin 1-EGFP fusion protein itself, three were known
Beclin 1 interaction proteins: Vps34/PtdIns3K, its activator Vps15 and UV Resistance
Associated Gene (UVRAG). The remaining three proteins were identified as two novel
proteins and Nuclear Receptor Binding Factor 2 (Nrbf2) (Fig. 2a). The first novel protein
(gi|27369860) has 492 amino acids (~60 kD), has two coiled-coil domains (aa 75-95 and
aa 148-178) and also contains homology to the conserved SMC (Structural Maintenance
of Chromosomes) motif. The second novel protein (gi|45708948) contains 941 amino
acids (~124 kD) and has a conserved RUN (for RPIP8, UNC-14 and NESCA) domain (aa
49-190) near the N-terminus, a cysteine-rich domain (aa 837-890) near the C-terminus,
and a coiled-coil domain (aa 488-508) in the central region. Since yeast Atg6p binds to
either Atg14p or Vps38p, alignment study was performed between the two novel proteins
and Atg14p or Vps38p. The first novel protein showed a modest 15% homology to yeast
Atg14p, therefore was named Atg14-Like (Atg14L) (Fig. 3). The second novel protein
showed no significant homology to either Atg14p or Vps38p, therefore was named after
its domain structure as Rubicon for RUN domain and cysteine-rich domain containing,
Beclin 1-interacting protein (Fig. 2b).
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Figure 1-3. Moderate homology between Atg14L and yeast Atg14
Protein sequences of Atg14L and yeast Atg14 were aligned to analyze possible homology
between them. Alignment was done suing T-Coffee package (Tree based Consistency
Objective Function For AlignmEnt Evaluation) available at server: www.tcoffee.org.,
and analysis was performed with GeneDoc application. The exact match between Atg14L
and yeast Atg14 is 15%, and juxtaposition greater than zero is 27%. The numbers
indicate similar groups: 1, DN; 2, EQ; 3, ST; 4, KR; 5, FYW; 6, LIVM.
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Figure 1-3

2.4 Confirmation of interaction with immunoprecipitation
To confirm specific interaction between identified proteins and Beclin 1, in vitro
reverse immunoprecipitation was performed in cultured cells. Atg14L, Rubicon and
Nrbf2 were cloned into pEGFP-N3 vector and pCMV-FLAG2 vector, and constructs
were transfected into human embryonic kidney (HEK) 293T cells to express C-terminal
EGFP-tagged or N-terminal FLAG-tagged proteins. Cell lysates were collected and
immunoprecipitations were performed using either anti-GFP or anti-FLAG antibody.
Both antibodies pulled down endogenous Beclin 1 as well as tagged proteins (Fig. 2c and
2d). Therefore the interaction between Beclin 1 and the three identified proteins is indeed
real and specific, and is not dependent on protein tags. Among these three identified
proteins, Atg14L and Rubicon pulled down much more Beclin 1 than Nrbf2, suggesting
that Atg14L and Rubicon interact with Beclin 1 much more strongly than Nrbf2.
Therefore, we decided to focus our study on Atg14L and Rubicon first.

2.5 Mapping binding domains
Beclin 1 has three domains: Bcl-2-binding domain (BD), coiled-coil domain
(CCD) and evolutionary conserved domain (ECD). Bcl-2 binding domain, as the name
indicates, is essential for interaction between Beclin 1 and Bcl-2 (Pattingre et al., 2005).
The evolutionary conserved domain is important for interaction between Beclin 1 and
Vps34/PtdIns3K, while the coiled-coil domain was shown to be mediating direct binding
between Beclin 1 and UVRAG (Furuya et al., 2005; Liang et al., 2006). In order to
determine which domains within Beclin 1 are mediating its interaction with Atg14L and
Rubicon, either single domains of Beclin 1 or two neighboring domains in different
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Figure 1-4. Mapping of the binding domains within Beclin 1 that mediate its
interaction with Atg14L and Rubicon
(a) Schematic representations of Beclin 1 domain structures and the construction of
multiple deletion mutants. All Beclin 1 mutants were tagged with FLAG at N-termini.
(b and c) Domains within Beclin 1 that mediate its binding with Atg14L or Rubicon.
HEK293T cells were co-transfected with FLAG-tagged Beclin 1 mutant constructs and
GFP-tagged full-length Atg14L (c) or Rubicon (d). The immunoprecipitation was
performed with anti-GFP antibody, followed by Western blot with anti-FLAG antibody.
The results of these experiments are summarized in a table under panel c and d. “+” or
“-” indicated positive or negative interactions between the tested protein domains. These
experiments showed that coiled-coil domain of Beclin 1 alone (FlAG-CCD) is sufficient
for binding with Atg14L but with evolutionarily conserved domain added (FLAG-CE)
the binding became much stronger; only FLAG-CE of Beclin 1, not other Beclin 1
mutants, bound to Rubicon. Abbreviations: B – Bcl2 binding domain, C – Coiled-coil
domain, and E – evolutionarily conserved domain.
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combinations were cloned into pCMV-FLAG2 vector to generate a series of deletion
mutants (Fig. 4a). These mutation constructs were co-transfected into HEK 293T cells
with either Atg14L-EGFP or Rubicon-EGFP, and immunoprecipitation was performed
using anti-GFP antibody, followed by western blot using anti-FLAG antibody. As a result,
Atg14L-EGFP pulled down FLAG-CCD, FLAG-BC (BD and CCD) and FLAG-CE
(CCD and ECD), suggesting that CCD of Beclin 1 alone is sufficient for its interaction
with Atg14L. Interestingly, the amount of immunoprecipitated FLAG-CE was
significantly higher than that of FLAG-CCD, while the amount of immunoprecipitated
FLAG-BC was comparable to that of FLAG-CCD, suggesting that ECD of Beclin 1 is
not essential for but greatly enhances its interaction with Atg14L (Fig. 4b). Meanwhile,
Rubicon-EGFP pulled down only FLAG-CE, but not any other deletion mutant of Beclin
1, suggesting that CCD and ECD of Beclin 1 are both required for its interaction with
Rubicon (Fig. 4c).
A similar strategy was used to determine the domains within Atg14L and Rubicon
that mediate their binding to Beclin 1. A series of deletion mutants of Atg14L and
Rubicon were generated and transfected into HEK293T cells to test their ability to pull
down endogenous Beclin 1 and Vps34/PtdIns3K proteins (Fig. 5a). Atg14L-EGFP with
the first coiled-coil domain deleted pulled down smaller amount of endogenous Beclin 1
than full length Atg14L-EGFP, and when both coiled-coil domains were deleted, no
endogenous Beclin 1 was detectable from immunoprecipitation. This result suggested
that both coiled-coil domains within Atg14L are important for it to maintain sufficient
interaction with Beclin 1. Likewise, Atg14L without coiled-coil domains was not able
to pull down Vps34/PtdIns3K either (Fig. 5b).
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Figure 1-5. Mapping domains within Atg14L and Rubicon that are required for
their interaction with Beclin 1
(a) Schematic representations of Atg14L and Rubicon domain structures and the
construction of multiple deletion mutants. All Atg14L and Rubicon mutants were tagged
with EGFP at C-termini.
(b and c) Domains within Atg14L or Rubicon that are required for their binding with
Beclin 1. HEK293T cells were transfected with EGFP-tagged Atg14L (b) or Rubicon (c)
mutant constructs. The immunoprecipitation was performed with anti-GFP antibody,
followed by Western blot analyses of endogenous Beclin 1 and Vps34/PtdIns3K with
anti-Beclin 1 and Vps34/PtdIns3K antibodies. The results of these experiments are
summarized in a table at bottom of panel b and c. “+” or “-” indicated positive or
negative interactions between the tested protein domains. These experiments showed that
both CCD1 and CCD2 of Atg14L are important for its binding to Beclin 1. Meanwhile,
neither RUN nor Cys-rich domain of Rubicon is required for its binding to Beclin 1. Thus,
central region containing CCD is important for the binding. In addition, Rubicon mutants
lacking RUN, Cys-rich domain or both domains have increased binding to Beclin1.
Abbreviations: RUN – RUN domain, Cys– cysteine-rich domain.
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Interestingly, when either RUN domain or cysteine-rich domain was deleted from
Rubicon-EGFP, larger amount of endogenous Beclin 1 was immunoprecipitated, and
Rubicon-EGFP with both domains simultaneously deleted pulled down the largest
amount of Beclin 1. It is therefore suggested that RUN domain and cysteine-rich domain
are not only unnecessary but also somehow inhibitory for the interaction between
Rubicon and Beclin 1, and that the interaction with Beclin 1 is probably mediated by the
coiled-coil domain in the central region of Rubicon. The same pattern was observed for
interaction between Rubicon and Vps34//PtdIns3K (Fig. 5c).

2.6 Identification of Beclin 1-containing protein complexes
In yeast, Atg6p/Vps30p forms two distinctive protein complexes. One contains
Atg14p and is essential for autophagy induction, and the other contains Vps38p and
functions in vacuolar protein carboxypeptidase Y (CPY) sorting pathway (Kihara et al.,
2001b). However in mammalian cells it is still unknown whether there are multiple
Beclin 1 complexes and what are the components of the complex(es). The in vivo
immunoprecipitation in this study identified at least six Beclin 1 interaction proteins, and
it is an interesting question how many protein complexes these proteins can form. To
answer this question, immunoprecipitation was first performed in NIH/3T3 mouse
fibroblast cells using anti-Atg14L and anti-Rubicon antibodies. As a result, anti-Atg14L
antibody pulled down Beclin 1 and Vps34/PtdIns3K, but not Rubicon or UVRAG, while
anti-Rubicon antibody pulled down Beclin 1 and Vps34/PtdIns3K as well as UVRAG,
but not Atg14L (Fig. 6a). This suggested that like yeast there may also be distinctive
multiple Beclin 1 complexes in mammalian cells as well, that Atg14L and Rubicon may
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Figure 1-6. Analysis of protein interactions among endogenous proteins in NIH/3T3
cells and HEK293 cells stably expressing Atg14L-EGFP or Rubicon-EGFP
(a) Immunoprecipitation of endogenous proteins that interact with Atg14L and Rubicon
using anti-Atg14L and anti-Rubicon antibodies from NIH/3T3 cell lysate. The control
experiments were preformed using the corresponding pre-immune serum for each
antibody. The whole cell lysate (WCL) and immunoprecipitated samples (IP) were
examined by western blot using antibodies against UVRAG, Vps34/PtdIns3K, Atg14L
and Rubicon.
(b) Immunoprecipitation of endogenous proteins that interact with Atg14L and Rubicon
using anti-GFP antibodies from HEK293 cells stably expressing Atg14L-EGFP or
Rubicon-EGFP. The whole cell lysate (WCL) and immunoprecipitated samples (IP) were
examined by western blot with antibodies against UVRAG, GFP, Vps34//PtdIns3K and
Beclin 1. Atg14L-EGFP co-immunoprecipitated with Vps34 and Beclin 1; RubiconEGFP co-immunoprecipitated with Vps34, Beclin 1 and UVRAG.
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exist in separate Beclin 1-containing protein complexes, and that UVRAG may be in the
same complex with Rubicon but not with Atg14L. Consistent with this idea,
immunoprecipitation with anti-GFP antibody performed in HEK293 cells stably
expressing either Atg14L-EGFP or Rubicon-EGFP showed that only Rubicon-EGFP
pulled down UVRAG although they both pulled down endogenous Beclin 1 and
Vps34/PtdIns3K (Fig. 6b).
To further characterize the composition of possible Beclin 1 protein complexes in
vivo, size exclusion chromatography (gel filtration) was performed. In this technique
protein complexes are separated according to their sizes (uisng mild condition). Wildtype or “rescued” mouse livers were homogenized and soluble cytosolic protein extract
was prepared with centrifugation, after which the extract was run through a column.
Eighty fractions were collected and analyzed by western blot using anti-Atg14L, antiRubicon, anti-Vps34/PtdIns3K, anti-Beclin 1 and anti-UVRAG antibodies. From both
wild-type and “rescued” mice, Vps34/PtdIns3K and Beclin 1 proteins were detected in
similar fractions and their levels peaked in the same fractions of 39-40 (Beclin 1-GFP in
“rescued” mice). Interestingly, Atg14L and Rubicon levels also showed similar
distribution among all fractions and the strongest signals in the similar fractions (Figs. 7a
& 7b), suggesting that these fractions contain a major Beclin 1-Vps34/PtdIns3K complex
that may include both Atg14L and Rubicon proteins. From protein size markers, it was
estimated that the size of this protein complex was over 700 kD.
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Figure 1-7. Analysis of protein composition in the Beclin 1 complex(es)
(a) Western blot analyses of Beclin 1, Vps34, Atg14L and Rubicon in the gel filtration
fractions from wild type mouse liver extract. The peak levels of each protein were found
co-eluded in the same fractions (39-40). Atg14L was also found eluted at the second peak
levels in later fractions (53-54). The cell lysate of FLAG-Atg14L-transfected HEK 293T
was loaded as a positive control (labeled with “1”) for the migration position of the
Atg14L protein. The adjacent lane (labeled with “2) was loaded with cell lysates without
transfection.
(b) Western blot analyses of Beclin 1, Vps34, Atg14L and Rubicon in the gel filtration
fractions from the “rescued” mice liver samples. The liver lysate was prepared from
“rescued” mice beclin 1

–/–

; beclin 1-GFP and applied in gel filtration experiment.

Western blot analyses of Beclin 1, Vps34, Atg14L and Rubicon in the gel filtration
fractions is shown. The peak levels of each protein were found co-eluded in the same
fractions (~41-43). Atg14L was also found eluted at the second peak levels in later
fractions (53-55). These results are consistent with the observation using wild-type mice
(a).
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To validate the protein detection by anti-Atg14L or anti-Rubicon antibodies in the
above study, the same experiment was repeated using cell lysate from HEK293 cells
stably expressing either Atg14L-EGFP or Rubicon-EGFP, followed by western blot
analyses with anti-GFP and anti-Beclin 1 antibodies (Fig. 8). The results from the
Atg14L-EGFP stable cell lysate again showed that the fractions containing peak levels of
Beclin 1 overlapped with that of Atg14L-EGFP (both peak fractions eluted at 39-40; Fig.
8), confirming the results using anti-Atg14L antibody for detecting endogenous proteins
in the liver (Fig. 7). Interestingly, the samples prepared from starved Atg14L-EGFP
stable cells showed no difference in the distribution pattern for Atg14L or Beclin 1 as
compared to that from non-starved cells (Fig. 8), suggesting that starvation does not
increase or decrease the binding between Atg14L and Beclin 1. Similar studies using
lysate from Rubicon-EGFP stable cells also confirmed the results using anti-Rubicon
antibodies for detecting endogenous Rubicon protein in mouse liver, and starvation did
not change the interaction between Rubicon and Beclin 1 (Fig. 8).
Western blot was also performed on liver and cell lysate fractions with UVRAG
antibody. However, no clear signal was detected. The possible reason may be the quality
of the anti-UVRAG antibody used, or that the binding of UVRAG in the whole protein
complex is not stable or strong enough to endure the experimental procedures of gel
filtration, and therefore UVRAG may have eluted as single molecules in late fractions
that were not collected.
In conclusion, gel filtration experiments showed that there is one major in vivo
Beclin 1-containing protein complex that contains both Atg14L and Rubicon, and that
Atg14L may exist in another smaller complex as well.
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Figure 1-8. Gel filtration analyses of protein distribution using stably transfected
cells
(a) Western blot analyses of Atg14L-EGFP and Beclin 1 in the gel filtration fractions of
non-starved (left panel) and starved (for 2h, right panel) using Atg14L-EGFP HEK293
stable cell lysate. Atg14L-EGFP (recognized by anti-GFP antibody as a ca. 85 kDa band)
and Beclin 1 co-eluted in fractions around 39-40, supporting the specificity of the antiAtg14L antibody (Fig. 7a&b). No change in the elution pattern was detected after the
cells were starved for 2h.
(b) Western blot analyses of Rubicon-EGFP and Beclin 1 in the gel filtration fractions of
non-starved (left panel) and starved (for 2h, right panel) using Rubicon-EGFP HEK293
stable cell lysate. Rubicon-EGFP and Beclin 1 co-eluted in many fractions, supporting
the specificity of the anti-Rubicon antibody (Fig. 7a&b). No change in the elution pattern
was detected after the cells were starved for 2h.
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2.7 Co-immunoprecipitation
In order to confirm the results from gel filtration that Atg14L and Rubicon are
able to co-exist in the same protein complex, tagged proteins were expressed in cultured
HEK293T cells and co-immunoprecipitation with anti-GFP antibody was performed. As
a result, Atg14L-EGFP was able to pull down FLAG-Rubicon (Fig. 9a), and RubiconEGFP pulled down FLAG-Atg14L as well (Fig. 9b). In both cases, Atg14L-EGFP and
Rubicon-EGFP were able to pull down endogenous Beclin 1, indicating that Beclin 1 was
also in the protein complex. Since gel filtration results did not indicate binding of
UVRAG in the protein complex, co-immunoprecipitation was performed in HEK293T
cells to study the binding between UVRAG-EGFP and FLAG-Atg14L or FLAG-Rubicon.
With anti-GFP antibody, UVRAG-EGFP pulled down both FLAG-Atg14L and FLAGRubicon, as well as endogenous Beclin 1 and Vps34/PtdIns3K, indicating that UVRAG
can also be in the same protein complex (Fig. 9c).

2.8 Binding inter-relations
When multiple proteins form a protein complex, they may affect the binding
affinity of each other in either positive way, in which case a certain protein may increase
the binding between other proteins, or in negative way, in which case a certain protein
may inhibit the binding between other proteins. In order to study whether such
interactions exist among the proteins of Beclin 1-Vps34/PtdIns3K complex, cotransfection of tagged proteins and co-immunoprecipitation was performed.
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Figure 1-9. Protein interactions among Beclin 1, ATG14L, Rubicon and UVRAG
assayed in transiently transfected cells
(a-b) Co-immunoprecipitation experiments showing protein-protein interaction between
Atg14L and Rubicon. HEK293T cells were co-transfected with EGFP-tagged Atg14L
and FLAG-tagged Rubicon (a), or EGFP-tagged Rubicon and FLAG-tagged Atg14L (b).
Cell lysate was used for immunoprecipitation with anti-GFP antibody, followed by
western blot with anti-FLAG antibody. EGFP-tagged Atg14L was able to pull down
FLAG-tagged Rubicon (a), and vice versa (b). WCL: whole cell lysate; IP:
immunoprecipirated.
(c) Protein interaction between co-expressed UVRAG and Atg14L/Rubicon. HEK293T
cells were co-transfected with UVRAG-EGFP and FLAG-Atg14L or FLAG-Rubicon.
Immunoprecipitation was performed with anti-GFP antibody, followed by detection with
anti-FLAG antibody. The result shows that both FLAG-Atg14L and FLAG-Rubicon was
co-immunoprecipitated with UVRAG-EGFP.
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2.8.1 Atg14L increases, and Rubicon reduces, interaction between Beclin 1 and
Vps34/PtdIns3K
Previous study showed that in mammalian cells, almost all Beclin 1 protein forms
complexes with Vps34/PtdIns3K while not all Vps34/PtdIns3K is interacting with Beclin
1 (Kihara et al., 2001a). In order to study if the presence of Atg14L or Rubicon affects
the interaction between Beclin 1 and Vps34/PtdIns3K, two sets of co-transfection
experiments were performed. In the first set, Beclin 1-EGFP was co-transfected into
HEK293T cells with empty pCMV-FLAG vector, FLAG-tagged Atg14L or FLAGtagged Rubicon, followed by immunoprecipitation using anti-GFP antibody. The level of
endogenous Vps34/PtdIns3K protein that was immunoprecipitated with the anti-GFP
antibody was detected with western blot and compared. In the second set, Myc-tagged
Vps34/PtdIns3K was co-transfected into HEK293T cells with empty pCMV-FLAG
vector,

FLAG-tagged

Atg14L

or

FLAG-tagged

Rubicon,

followed

by

immunoprecipitation using anti-Myc antibody. And the level of endogenous Beclin 1
protein that was immunoprecipitated was detected and compared. In the first set,
compared to empty vector control, FLAG-Rubicon significantly reduced the level of
Vps34/PtdIns3K that was pulled down with Beclin 1-EGFP while FLAG-Atg14L did not
show significant effect (Fig. 10a). Meanwhile in the second set, when empty vector was
co-transfected Myc-Vps34/PtdIns3K was only able to pull down extremely small amount
of endogenous Beclin 1, probably due to the low efficiency of immunoprecipitation with
anti-Myc antibody. However when FLAG-Atg14L was co-transfected, an increased
amount of endogenous Beclin 1 was pulled down. And with co-transfection of FLAGRubicon, the amount of Beclin 1 pulled down was too small to assess the effect of
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Figure 1-10. Binding inter-relationship among Beclin 1 interaction proteins
(a) Co-immunoprecipitation of endogenous Vps34/PtdIns3K with Beclin 1-EGFP in the
presence of over-expressed FLAG-Atg14L or FLAG-Rubicon. Beclin 1-EGFP was coexpressed with FLAG-Atg14L, FLAG-Rubicon or control FLAG vector in HEK 293T
cells. Immunoprecipitation was performed with anti-GFP antibody, followed by western
blot with anti-Vps34 antibody to detect endogenous Vps34/PtdIns3K. Notably, overexpression of FLAG-Rubicon, but not FLAG-Atg14L, repressed the amount of
endogenous Vps34/PtdIns3K that interacted with Beclin 1-EGFP.
(b) Co-immunoprecipitation of endogenous Beclin 1 with Myc-Vps34/PtdIns3K in the
presence of over-expressed FLAG-Atg14L or FLAG-Rubicon. Immunoprecipitation was
performed with anti-Myc antibody, followed by Western blot with anti-Beclin 1 antibody
to detect Endogenous Beclin 1. Over-expression of FLAG-Atg14L increased the amount
of endogenous Beclin 1 that interacted with Myc-Vps34/PtdIns3K.
(c) Co-immunoprecipitation of Beclin 1 and Vps34/PtdIns3K with Atg14L-EGFP or
Rubicon-EGFP. Atg14L-EGFP or Rubicon-EGFP was co-expressed with MycVps34/PtdIns3K, either with or without Beclin 1-AsRed in HEK293T cells.
Immunoprecipitation was performed using anti-GFP antibody followed by blotting with
anti-Vps34/PtdIns3K and anti-Beclin 1 antibodies. Over-expression of Beclin 1-AsRed
increased the binding between Atg14L-EGFP and Myc-Vps34/PtdIns3K
(d-e) Effect of Beclin 1 over-expression on protein interaction between co-expressed
UVRAG and Atg14L/Rubicon. UVRAG-EGFP was co-expressed with either FLAGAtg14L or FLAG-Rubicon in HEK 293T cells, in the absence or in the presence of Beclin
1-Myc. Immunoprecipitation was performed with anti-GFP antibody, followed by
detection with anti-FLAG and anti-Myc antibodies. The results show that Beclin 1 overexpression markedly increased the amount of FLAG-Rubicon that was coimmunoprecipitated with UVRAG-EGFP (e) while having little effect on interaction
between FLAG-Atg14L and UVRAG-EGFP (d).
For (a-e), WCL: whole cell lysate; IP: immunoprecipirated.
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Rubicon (Fig. 10b). The results from these two sets of co-immunoprecipitation
experiments suggested that Atg14L increased while Rubicon reduced the interaction
between Beclin 1 and Vps34/PtdIns3K.

2.8.2 Effect of Beclin 1 on interaction between Atg14L/Rubicon and Vps34/PtdIns3K
As a component of the Vps34/PtdIns3K complex, Beclin 1 may as well affect
binding of other protein components to the Vps34/PtdIns3K. Therefore co-transfection
and immunoprecipitation experiments were performed to test the effect of Beclin 1 on
interaction between Atg14L or Rubicon and Vps34/PtdIns3K. For this purpose, triple
transfection was performed using Atg14L-EGFP/Rubicon-EGFP, Myc-Vps34/PtdIns3K
and either empty pAsRed2-N1 vector or Beclin 1-AsRed. Immuno-precipitation was
performed with anti-GFP antibody, and the level of Myc-Vps34/PtdIns3K that was pulled
down was detected with Vps34 antibody and compared between the conditions of empty
vector co-trasfection and Beclin 1-AsRed co-transfection. As a result, the presence of
Beclin 1-AsRed greatly increased the amount of Myc-Vps34/PtdIns3K that was pulled
down with Atg14L-EGFP yet had no significant effect on that pulled down with
Rubicon-EGFP. This suggested that Beclin 1 increased the interaction between Atg14L
and Vps34/PtdIns3K but did not affect the interaction between Rubicon and
Vps34/PtdIns3K.
Taken together, the co-immunoprecipitation experiments showed that Beclin 1
and Atg14L increase each other’s interaction with Vps34/PtdIns3K, and that Rubicon
inhibits the interaction between Beclin 1 and Vps34/PtdIns3K.
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2.8.3 Effect of Beclin 1 on interaction between Atg14L/Rubicon and UVRAG
Immunoprecipitation with Atg14L or Rubicon antibodies from NIH/3T3 cells or
with GFP antibody from HEK293 cells stably expressing Atg14L-EGFP or RubiconEGFP showed that Rubicon has strong interaction with UVRAG but Atg14L does not
(Fig. 6a and 6b). Meanwhile, immunoprecipitation from transiently transfected cells
showed that UVRAG could be in the same complex with both Atg14L and Rubicon. In
order to study how their interaction is related to Beclin 1, triple transfection was
performed in which UVRAG-EGFP, FLAG-Atg14L or FLAG-Rubicon, and either
control empty vector or Beclin 1-Myc were co-transfected into HEK293T cells.
Immunoprecipitation was performed with anti-GFP antibody, followed by western blot
with anti-FLAG and anti-Myc antibodies. The results showed that the amount of FLAGRubicon that immunoprecipitated with UVRAG-EGFP increased dramatically when
Beclin 1 was co-transfected, indicating that Beclin1 significantly increased binding
between UVRAG and Rubicon (Fig. 10e). However Beclin 1 co-transfection had no
effect on the interaction between UVRAG-EGFP and FLAG-Atg14L (Fig. 10d).

2.9 Functional assays of Atg14L
2.9.1 Atg14L positively regulates autophagy
Beclin 1 forms a protein complex with Vps34/PtdIns3K and regulates the level of
autophagy in mammalian cells. In order to study the function of the novel protein Atg14L,
its effect on autophagy levels was first studied. RNA interference (RNAi) was used to
suppress the expression of endogenous Atg14L gene and knock down the protein level of
Atg14L in NIH/3T3 cells. First, LC3 protein levels from the cell lysate were examined
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after siRNA transfection. LC3 is the mammalian ortholog of Atg8, and undergoes
modification from LC3 I form that is localized in the cytosol to LC3 II form that is bound
to the autophagosome membrane. Anti-LC3 antibody detects both forms, and the ratio
between the cytosolic I form and the membrane bound II form is correlated with the
number of autophagosome and therefore the autophagy level in the cells. Compared to
control siRNA, Atg14L siRNA transfection greatly increased the LC3 II form level,
indicating that autophagy level was changed (Fig. 11a). However, the increase in LC3 II
form level can be either from an increase of autophagosome formation, which means an
increase of autophagy level, or from a decrease of lysosomal degradation of
autophagosomes, which means a decrease of autophagy level. Interestingly, transfection
of Beclin 1 siRNA also induced a significant increase of LC3 II level that is comparable
to that induced by Atg14L siRNA transfection. Beclin 1 functions in autophagy induction
and deletion of Beclin 1 inhibits autophagy. The similar changes in LC3 II form levels
that Atg14L siRNA and Beclin 1 siRNA induced suggested that Atg14L is related to
autophagy regulation and that it may function in the same direction as Beclin 1. To
confirm the function of Atg14L on autophagy regulation, the level of another autophagy
related protein, p62/SQSTM1 was examined. P62/SQSTM1 was identified as a LC3
interaction protein and is degraded by autophagy (Komatsu et al., 2007b; Pankiv et al.,
2007). Therefore the p62/SQSTM1 protein level can be used as a more reliable marker
for autophagy level. Western blot with anti-p62/SQSTM1 antibody showed that
transfection of both Atg14L and Beclin 1 siRNA significantly increased the
p62/SQSTM1 protein level compared to control siRNA. This result confirmed that like
Beclin 1, knockdown of Atg14L protein resulted in accumulation of p62/SQSTM1,
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Figure 1-11. Atg14L functions in positive regulation of autophagy
(a) Beclin 1 or Atg14L RNAi knock-down in the NIH/3T3 cells led to increased levels of
p62/SQSTM1 and LC3 II form as detected with anti-p62/SQSTM1 and LC3 antibodies
under both normal (left panel) and nutrient-starvation conditions (right panel). Notably,
Beclin 1 RNAi knock-down markedly reduced levels of Atg14L expression. -actin was
blotted as the loading control.
(b) Confocal images of MLE12 cells stably expressing GFP-LC3 showed that Atg14L
RNAi knock-down resulted in markedly increased number of large size GFP-LC3 puncta,
as compared to the control RNAi treatment. Scale bar, 10 m.
(c-d) Confocal images of MLE12 cells stably expressing GFP-LC3 showed that Atg14LRNAi-induced large-size GFP-LC3 puncta (in green) colocalized with p62/SQSTM1 (c,
in red) and ubiquitin (d, in red). Scale bar, 10 m.
(e) Atg14L siRNA, as compared to control siRNA, decreased long-lived protein
degradation in NIH/3T3 cells under both normal (p=0.007) and starvation (p=5E-6)
conditions (asterisks, one-tailed Student’s t-test with equal variances, n = 4). This
difference was diminished when the starved cells were treated with 3-methyladenine
(3MA), a PI-3K inhibitor.
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thereby indicating that like Beclin 1, knockdown of Atg14L impaired autophagy level in
the cells. When cells were deprived of serum and amino acids to induce autophagy,
transfection of Beclin 1 or Atg14L siRNA resulted in the same accumulation of
p62/SQSTM1 and both LC3 I and II forms, indicating that autophagy was inhibited as
well under starvation conditions (Fig. 11b). Interestingly, Beclin 1 siRNA transfection
also resulted in a significant decrease of Atg14L protein level, suggesting that Beclin 1
may be essential for stabilization of Atg14L.
In a parallel experiment, Atg14L protein levels were knocked down in MLE12
cells that stably expressed the autophagy reporter, GFP-LC3 fusion protein. Compared to
control siRNA, Atg14L siRNA transfection resulted in accumulation of many large-sized
punctate structures that were positive for GFP-LC3 (Fig. 11c). These structures were
stained positively with anti-p62/SQSTM1 and anti-ubiquitin antibodies, indicating that
they are accumulation of ubiquitinated proteins they failed to be degraded by lysosomes
because of down-regulation of autophagy (Fig. 11d).
To further confirm the positive regulation of autophagy by Atg14L, long-lived
protein degradation rate was measured and compared in control or Atg14L siRNA
trasnfected NIH/3T3 cells. Unlike short-lived proteins that are degraded by ubiquitinproteasome system, long-lived proteins are degraded by autophagy and therefore the rate
of degradation can be used as an indicator of the level of autophagy. When the long-lived
protein degradation rate in control siRNA transfected cells under normal culture
conditions was set as 1.00 fold as normalization standard, Atg14L siRNA transfection
reduced the degradation to 0.90 fold, which is a small yet significant difference (p<0.001).
Upon starvation, autophagy in cells was induced and the long-lived protein degradation
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rate in control RNAi transfected cells increased to 2.73 folds, and again Atg14L siRNA
transfection reduced it to 1.71 folds (~37%, p=5E-6). Finally when cells were put under
starvation conditions and treated with a specific autophagy inhibitor 3-methyladenie (3MA), long-lived protein degradation rates in control siRNA and Atg14L siRNA
transfected cell were reduced to 0.83 fold and 0.77 fold respectively, and no significant
difference was observed between the two conditions (Fig. 11e). These results indicated
that knockdown of Atg14L protein level indeed inhibited autophagy, therefore Atg14L
positively regulates autophagy.

2.9.2 Atg14L positively regulates Vps34/PtdIns3K lipid kinase activity
Vps34/PtdIns3K is essential for autophagy induction, and it is a type III
phosphoinositide 3 (PI 3)-kinase that generates phosphotidylinositol 3-phosphate
(PtdIns(3)P) from the substrate phosphatidylinositol (PI). Recently identified Beclin 1
interaction proteins UVRAG and Bif-1 both positively regulate Vps34/PtdIns3K kinase
activity and autophagy. To study whether Atg14L may also function on Vps34/PtdIns3K,
a kinase activity assay was performed. A plasmid that contains both Myc-tagged
Vps34/PtdIns3K and its co-activator Vps15 was used, since the co-expression of Vps15
was reported to enhance Vps34/PtdIns3K kinase activity and therefore increase the
sensitivity of the assay (Yan et al., 2008). Myc-Vps34/PtdIns3K-Vps15 was cotransfected with either empty pCMV-FLAG vector or FLAG-Atg14L, and IP was
performed using Myc antibody. Immunoprecipitated Myc-Vps34/PtdIns3K was
subsequently used for in vitro kinase activity assay, and generated PtdIns(3)P was
separated with thin layer chromatography (TLC) (Fig. 12a).
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Figure 1-12. Atg14L positively regulates Vps34/ PtdIns3K kinase activity
(a) HEK 293T cells were co-transfected with myc-Vps34/PtdIns3K-Vps15 and FLAGAtg14L or FLAG vector, either in the absence or in the presence of Beclin 1-EGFP. MycVps34-Vps15 was immunoprecipitated with anti-Myc antibody for the in vitro kinase
activity assay. The resulting radioactive PtdIns(3)P was separated by thin layer
chromatography (TLC) (lower panel), quantified and normalized against the amount of
immunoprecipitated myc-tagged Vps34/PtdIns3K as measured by Western blot (upper
panel).
(b) The quantified results showed that over-expressing Atg14L significantly up-regulated
the Vps34 kinase activity by 2.5 folds with simultaneous over-expression of Beclin 1
(asterisk, p=0.04, one-tailed Student’s t-test with unequal variances, n=5). Without overexpressed Beclin 1, no significant difference was observed.
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When only two plasmids were co-transfected, FLAG-Atg14L did not change the
Vps34/PtdIns3K kinase activity compared to empty control vector. However, when
Beclin 1-EGFP was co-transfected with FLAG-Atg14L, there was a significant 2.5 folds
change in Vps34/PtdIns3K kinase activity compared to control vector (Fig. 12b).
Therefore, Atg14L positively regulates Vps34/PtdIns3K kinase activity, and Beclin 1 is
essential for this regulatory function.

2.9.3 Beclin 1 and Atg14L synergistically promote autophagosome biogenesis
Although it has been shown that Beclin 1 is localized on trans-Golgi network
(TGN) and near mitochondria, the majority of it is diffusely localized throughout the
cytosol, and half of the protein is within soluble portion of the cells (Kihara et al., 2001a;
Pattingre et al., 2005). Staining of tissue sections from Beclin 1-EGFP mice also showed
diffuse intracellular localization of Beclin 1-EGFP in cells (Arsov et al., 2008). The
intracellular localization of Beclin 1-EGFP after transient transfection or in Beclin 1EGFP HEK293 stable cells was consistent with these previous reports (Fig. 13a).
Meanwhile, Atg14L-EGFP mainly showed diffuse intacellular localization in HEK293
cells stably expressing Atg14L-EGFP (Fig. 13a). In order to study the inter-relation
between localization of Beclin 1 and Atg14L, Beclin 1-AsRed and Atg14L-EGFP were
co-transfected into Hela cells. Upon co-transfection, both proteins showed dramatic
changes in intracellular localization and both became localized on numerous punctate
structures. On these punctate structures, Beclin 1-AsRed and Atg14L-EGFP showed
complete co-localization (Fig. 13b). In order to reveal the identity of the punctate
structures, electron microscopy (EM) studies were performed on HEK293T cells
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Figure 1-13.

Synergistic effects of Beclin 1 and Atg14L in promoting double

membrane formation
(a) Beclin 1-EGFP and Atg14L-EGFP are diffuse in cytoplasm of HEK-293 cells stably
transfected with Beclin 1-EGFP or Atg14L-EGFP plasmids. Scale bar: 10 m.
(b) Co-expression and co-localization of Atg14L-EGFP (green) & Beclin 1-AsRed (red)
on punctate structures in co-transfected HeLa cells, with Pearson’s coefficient (PC) 0.91.
Scale bar: 10 m.
(c) Electron microscopic images showed that co-transfection with Atg14L-EGFP and
Beclin 1-AsRed caused the formation of large size organelles (red asterisks) that were
often enwrapped with double membranes in HEK 293T cells: (c1) concentric membrane
“rings”; (c2) two large structures (3-5 m in diameter) containing materials with high
electron density. The inset shows high magnification of enwrapping double membranes;
(c3) formation of many autophagosomes (yellow arrows) in cytoplasm; (c4) Immunoelectron microscopic image showing a structure enwrapped with concentric membrane
“rings” labeled with anti-GFP antibody. Abbreviations: M – mitochondria, N – nucleus.
Scale bar: 500 nm.
(d) Co-localization of Beclin 1-myc (blue), Atg14L-AsRed (red) and GFP-LC3 (green).
HeLa cells stably expressing GFP-LC3 were transiently transfected with Beclin 1-myc
and Atg14L-AsRed and stained with anti-Myc antibody. Scale bar: 10 m.
(e-f) Atg12-EGFP and Atg5-EGFP (green) were colocalized with the puncta associated
with the Atg14L-AsRed (red) and Beclin 1-Myc (blue) (arrows) in transfected HeLa cells.
Some of these puncta (yellow arrows) appeared to be “ring” shape (see the inset). Scale
bar: 10 m.
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co-transfected with Beclin 1-AsRed and Atg14L-EGFP. Under EM, numbers of electron
dense structures that have large-size (~3-5 micron in diameter) were observed, and such
structures were virtually absent in single plasmid or control empty vector transfected cells
(data not shown). Some of these structures displayed concentric “rings” with double
membranes (Fig. 13c1), and many were large vacuoles filled with materials of high
electron density (Fig. 13c2). Interestingly, these large organelles were enwrapped with
double-membranes (e.g., Fig. 13c2 inset), which are distinguished from typical
aggresomes or protein aggregates that are usually not associated with limiting membranes.
Meanwhile, increased numbers of double membrane autophagosomes were also observed
in the cells overexpressing Atg14L-EGFP and Beclin 1-AsRed (Fig. 13c3). In addition,
as shown by immuno-EM using anti-GFP antibody, these large organelles were mostly
positive for Atg14L-EGFP (Fig. 13c4), indicating that they are the punctate structures on
which Beclin 1-AsRed and Atg14L-EGFP co-localized under fluorescence microscopy
(Fig. 13b).
Like Atg6 in yeast, Beclin 1 functions with Vps34/PtdIns3K at the nucleation step
of autophagosome formation. They are localized on pre-autophagosomal structure (PAS),
and are also essential for localization of other autophagy protein to PAS (Kihara et al.,
2001b; Suzuki et al., 2001). To further study the relationship of Beclin 1-Atg14L-labeled
structures to other autophagy proteins, Beclin 1-Myc and Atg14L-AsRed were cotransfected into HeLa cells stably expressing GFP-LC3. Again, co-expression of Beclin
1-Myc (blue) and Atg14L-AsRed (red) causes formation of Beclin 1-BISC punctate
structures, and GFP-LC3 was also localized on these structures (green) (Fig. 13d),
suggesting that the Beclin 1-Atg14L structures likely recruit LC3. Moreover, when
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transfection of Atg14L-AsRed, Beclin 1-Myc and EGFP-Atg12 (or EGFP-Atg5) was
performed in HeLa cells, EGFP-Atg12 or EGFP-Atg5 (green) was also co-localized on
the Atg14L-Beclin 1 punctate structures (red and blue, respectivley) (Fig. 13e&f),
suggesting that these Beclin 1-Atg14L structures may also recruit Atg12 and Atg5, whose
conjugation is required for autophagosome expansion and association of LC3 to
autophagosome membranes (Mizushima et al., 2001).
Taken together, the results suggest that Beclin 1 and Atg14L synergistically
induce formation of specific structures on which autophagy protein Atg5, Atg12 and LC3
are localized, and that they also synergistically promote the formation of double
membranes during the process of autophagosome biogenesis.

2.10 The functions of Rubicon
2.10.1 Rubicon negatively regulates autophagy
To study the possible functions of Rubicon on autophagy regulation, the Rubicon
protein level was knocked down in NIH/3T3 cells with siRNA transfection, after which
LC3 and p62/SQSTM1 protein levels were examined with western blot. Compared to
control siRNA, Rubicon siRNA transfection reduced both LC3 I/II forms and
p62/SQSTM1 levels, indicating that knockdown of Rubicon induced activation of
autophagy, which resulted in elevated p62/SQSTM1 protein degradation and faster LC3
I/II protein turnover by autophagy (Fig. 14a). When transfected cells were deprived of
serum and amino acids, the same results were observed, indicating that when autophagy
was induced by starvation, knockdown of Rubicon further activated autophagy (Fig. 14a).
These results suggest that Rubicon inhibits autophagy. In order to confirm this, the effect
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Figure 1-14. Rubicon is a negative regulator of autophagy
(a) Rubicon RNAi knock-down in the NIH/3T3 cells led to decreased levels of
p62/SQSTM1 and LC3 II as detected with anti-p62/SQSTM1 and LC3 antibodies under
both normal and starvation conditions.
(b) Over-expression of Rubicon resulted in increased levels of p62/SQSTM1 under both
normal and starvation conditions in both HEK293 cells stably expressing Rubicon-EGFP
(upper panel) and HEK293T cells transiently transfected with Rubicon-EGFP (lower
panel). The control cells were transfected with EGFP-N3 vector.
(c) Vps34/PtdIns3K kinase activity assay. HEK293T cells were co-transfected with MycVps34/PtdIns3K-Vps15 and FLAG-tagged Rubicon or empty vector, either in the
absence or in the presence of Beclin 1-EGFP. Myc-tagged Vps34/PtdIns3K that was
immunoprecipitated using anti-Myc antibody was used for in votro kinase activity assay.
The resulting radioactive PtdIns(3)P was separated by thin layer chromatography (TLC)
and visualized by radiograph. The amount of radioactive PtdIns(3)P was normalized
against the amount of immunoprecipitated Myc-tagged Vps34/PtdIns3K.
(d) The results were quantified and showed that in the absence of Beclin 1, overexpessed
Rubicon significantly reduced Vps34/PtdIns3K kinase activity (ratio=0.58, p=0.04 for the
one-tailed Student’s t-test with unequal variances, n=4, labeled by asterisk). No
significant difference was observed when Beclin 1 was co-transfected.
(e) Starvation increased interaction between Rubicon and Beclin 1. HEK293T cells were
transiently transfected with Atg14L-EGFP or Rubicon-EGFP. Cells were either
maintained in complete media or under starvation conditions for 4 hours. After that
immunoprecipitation was performed using anti-GFP antibody. Anti-Beclin 1 and antiVps34/PtdIns3K antibody were used to detect the endogenous proteins that were
immunoprecipitated.
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of Rubicon over-expression on autophagy levels was studied in transiently transfected
HEK293T cells or in HEK293 cells stably expressing Rubicon-EGFP. Compared to
control conditions, under both normal culture conditions and starvation conditions, overexpression of Rubicon-EGFP resulted in increased p62/SQSTM1 protein levels in both
transiently transfected cells and stable cells, indicating that Rubicon indeed inhibits
autophagy (Fig. 14b).

2.10.2 Rubicon negatively regulates Vps34/PtdIns3K kinase activity
Since Rubicon is associated with Beclin 1-Vps34/PtdIns3K complex, its
inhibitory effect on autophagy may be through regulation of Vps34/PtdIns3K kinase
activity. To test this possibility, Myc-Vps34/PtdIns3K-Vps15 was co-transfected with
either empty pCMV-FLAG vector or FLAG-Rubicon, and immunoprecipitated MycVps34/PtdIns3K was used for in vitro kinase activity assay (Fig. 14c). Compared to
control condition, co-transfection of FLAG-Rubicon significantly reduced the kinase
activity of Myc-Vps34/PtdIns3K. Interestingly, when Beclin 1-EGFP was also overexpressed in the cells, this reduction of kinase activity largely diminished, indicating that
Beclin 1 is not required for and furthermore interferes with the negative regulation of
Vps34/PtdIns3K by Rubicon (Fig. 14c&d).

2.10.3 Interaction between Beclin 1 and Rubicon increases under starvation conditions
Rubicon reduces the interaction between Beclin 1 and Vps34/PtdIns3K (Fig. 10a),
while Beclin 1 inhibits Rubicon’s regulation on Vps34/PtdIns3K (Fig. 14c&d). To
characterize the possible function of Beclin 1-Rubicon interaction in autophagy, how
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activation of autophagy affects this interaction was examined. To do this, HEK293T cells
transfected with Rubicon-EGFP were either maintained in normal culture media or
subjected to nutrient and amino acid starvation for 4 hours. Immunoprecipitation using
anti-GFP antibody was then performed and immunoprecipitated endogenous Beclin 1 and
Vps34/PtdIns3K were detected with western blot. Under starvation conditions, RubiconEGFP pulled down significantly larger amount of Beclin 1 and Vps34/PtdIns3K,
indicating that they have much stronger binding when autophagy is activated (Fig. 14e).
In contrast, the interaction between Atg14L and Beclin 1 or Vps34/PtdIns3K showed no
changes under starvation conditions (Fig. 14e).

2.10.4 Rubicon blocks autophagosome acidification and maturation
Vps34/PtdIns3K functions at various steps of intracellular membrane trafficking.
In order to identify which step of autophagy may be affected by Rubicon, a previously
developed double-tagged LC3 reporter, mCherry-GFP-LC3, was used to examine the
maturation of autophagosomes, such as autophagosome acidification following fusion
with late endosomes/lysosomes (Pankiv et al., 2007). Immature autophagosoms labeled
with mCherry-GFP-LC3 emit both GFP and mCherry fluorescence and will appear
yellow when two channels are merged under fluorescence microscope. However, since
GFP is pH sensitive and cannot emit green fluorescence in acidic environments,
mCherry-GFP-LC3 labeled mature autophagosomes that have fused with late
endosomes/lysosomes will only show red color (Fig. 15a). In Hela cells co-transfected
with FLAG-Rubicon and mCherry-GFP-LC3, the majority fluorescent punctate structures
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Figure 1-15. Rubicon blocks autophagosome maturation
(a)

Schematic
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of

mCherry-GFP-LC3

construct.
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Neutral

autophagosome will appear yellow under fluorescence microscope while mature
autophagsomes that have fused with lysosomes will appear red.
(b) Effect of over-expressing FLAG-Rubicon on autophagosome acidification, as
monitored by mCherry-GFP-LC3 fluorescence. HeLa cells were transiently cotransfected with mCherry-GFP-LC3 and FLAG-Rubicon (or control FLAG vector). Cells
co-expressing mCherry-GFP-LC3 and control FLAG vector contained many red-only
puncta along with yellow (indicating presence of both red and green) puncta, suggesting
both autolysosomes and nascent autophagosomes (upper panel). In contrast, cells coexpressing mCherry-GFP-LC3 and FLAG-Rubicon contained primarily yellow puncta,
suggesting only nascent autophagosomes (lower panel, white arrows). Notably, some
cells that did not express detectable levels of FLAG-Rubicon contained many red-only
puncta (low panel, yellow arrows).
(c) Quantitation of the results in (b) showed that over-expressing FLAG-Rubicon
drastically reduced the percentage of red-only puncta (mCherry-LC3) from 39% in the
control FLAG vector-transfected cells to 2% in the FLAG-Rubicon-transfected cells
(asterisk, p=2E-26, one-tailed Student’s t-test with unequal variances, n=30), indicating
that over-expression of Rubicon blocks autophagosome acidification or maturation.
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observed were yellow, indicating that most mCherry-GFP-LC3 labeled autophagosomes
in the cells are immature, and only about 2% of the autophagosomes were mature (Fig.
15b and 15c). In contrast, in cells that were co-transfected with empty pCMV-FLAG
vector or those that did not express detectable levels of FLAG-Rubicon, a significantly
higher number of red punctate structures, which represented mature autophagosomes,
were observed (Fig. 15b and 15c). These results suggest that over-expression of Rubicon
blocked autophagosome acidification or maturation.
Taken the above results together, it can be concluded that Rubicon negatively
regulates autophagy and that it may be functioning through negatively regulating
Vps34/PtdIns3K kinase activity and inhibiting autophagosome maturation.

2.10.5 Over-expression of Rubicon causes aberrant expansion of late endosomes/lysosomes
In cells transiently transfected with Rubicon-EGFP or cells that stably express
Rubicon-EGFP, localization of Rubion-EGFP on large numbers of punctate and vesicular
structures was observed (Fig. 16a). Transient transfection of FLAG-Rubicon and staining
with FLAG antibody confirmed that the localization pattern was unique to Rubicon and
not due to EGFP tagging (data not shown). Some of these Rubicon-EGFP puncta were
large in size and exhibited “ring” shapes (Fig. 16a, yellow arrows). To study the identity
of these structures, Hela cells transiently transfected with Rubicon-EGFP were stained
with a series of cellular organelle markers. The results showed that the Rubicon-EGFP
structures were primarily positive for Lamp1, a late endosome/lysosome larker, although
a small portion of them were positive for EEA1, an early endosome marker (Fig. 16a and
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Figure 1-16. Over-expressing Rubicon causes aberrant expansion of late
endosomes/lysosomes
(a) Co-localization of Rubicon-EGFP-associated structures (green) with the late
endosome/lysosome marker Lamp1 (red, upper panel) (arrows) and partial co-localization
of Rubicon-EGFP-associated structures (green) with the MVB marker LBPA (red, lower
panel) (arrows) in the HeLa cells that were transfected with Rubicon-EGFP. Note that
some of the Rubicon-EGFP-associated structures displayed “ring”-shape (yellow arrows).
Scale bar: 10 m.
(b)
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aberrant

expansion

of

late

endosomes/lysosomes structures in the HEK 293T cells over-expressing Rubicon-EGFP.
These abnormal organelles are large in size and contained high (orange arrows) or low
(black arrows) electron density. Some enclose small vesicles (purple arrows) and some
resemble MVB (blue arrows). Scale bars: 500 nm.
(c) Representative ultrastructural images showing late endosome/lysosome-like structures
that are labeled by anti-GFP gold particles (panels 3-4) in the HEK 293T cells transiently
transfected with Rubicon-EGFP. These structures are enwrapped by double membranes
(panel 4 inset) and co-labeled by anti-GFP (developed by DAB) and anti-Lamp1 (gold
enhanced) (panels 5-7). Note that mitochondria are mostly negative for Rubicon-EGFP
(panel 4). The negative controls are without antibody (panels 1-2). M – mitochondria.
Scale bars: 200 nm.
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data not shown). In addition, some of the structures were positively stained with an
antibody against lysobisphosphatidic acid (LBPA) (Fig. 16b), an unusual eukaryotic lipid
found only in multi-vesicular body (MVB). These results suggest that the function of
Rubicon may also be related to endocytic pathway. In order to examine the RubiconEGFP-labeled structures at ultra-structural levels, electron microscopy (EM) analyses
were performed. Under EM, many abnormally large-sized vacuoles (1-5m in diameter)
were observed in Rubicon-EGFP-transfected cells (Fig. 16b). In contrast, these large
structures were not observed in cells over-expressing EGFP, Atg14L-EGFP or Beclin 1EGFP (data not shown). Some of these large vacuoles contained high electron density
(Fig. 16b1&2, orange arrows), characteristic of late endosomes/lysosomes; some had
relatively less content with overall low electron density (more transparent), which may
represent an early stage of endosomes (but with enlarged size) (Fig. 16b3, black arrows);
interestingly, some contained numerous small vesicles of multiple-layers (Fig. 16b2&4,
purple arrows), while others resembled multivesicular endosomal vesicles or MVB (Fig.
16c1&2, blue arrows). To ensure that these large organelles under EM are the same
structures as those observed under fluorescence microscopy (Fig. 16a), immuno-EM was
performed using anti-GFP antibody and extensive staining by the gold particles on the
large vacuoles was observed (Fig. 16c3&4). These gold particles were found primarily
associated to the outside of the limiting membranes, although some were also inside the
membranes (Fig. 16c3&4). In addition, the immuno-EM results also confirmed the colocalization of Rubicon-EGFP and Lamp1 at ultrastructural level, as shown by extensive
co-localization between anti-GFP antibody associated DAB and anti-Lamp1 antibody
associated gold particles (Fig. 16d5-7).
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2.10.6 C-terminal cysteine-rich domain is essential for Rubicon localization
Rubicon-EGFP exhibited distinctive punctate and vesicular localization in both
transiently transfected cells and stably expressing cells (Fig. 16a and 17a). In order to
identify which part of the Rubicon protein is critical for its intracellular localization, the
localization pattern of previously generated deletion mutants of Rubicon (Fig. 5a) was
studied in transiently transfected cells. When the N-terminal RUN domain was deleted,
Rubicon(RUN)-EGFP was still localized on numerous punctate and vesicular structures,
and this pattern was very similar to that of full length Rubicon-EGFP. However, when
the C-terminal cysteine-rich domain was deleted, Rubicon(C)-EGFP was localized
diffusely throughout the whole cytosol, and no punctate or vesicular structures were
observed. Furthermore, when both RUN and cysteine-rich domains were deleted,
Rubicon(RUN&C)-EGFP showed the same diffuse pattern as Rubicon(C)-EGFP (Fig.
17a). Therefore, the C-terminal cysteine-rich domain within Rubicon is essential for
maintaining its intracellular localization and possibly its function as well.
Bioinformatic analysis of Rubicon sequence revealed that the several cysteine
residues within the C-terminal cysteine-rich domain are conserved in FYVE domain, a
well-characterized motif specific for PtdIns(3)P binding (Fig. 17b) (Stenmark et al.,
2002). However, the sequence in Rubicon does not contain the key consensus sequences
of typical FYVE domain, i.e., WxxD, R[R/K]HHCR and RVC (Fig. 17b, red bars).
Moreover, Rubicon-EGFP from tansfected cell lysate failed to bind to PtdIns(3)Pconjugated sepharose beads, indicating that unlike other FYVE domain containing
proteins, Rubicon does not bind to PtdIns(3)P directly (data not shown). Nevertheless,
when Rubicon-AsRed was co-transfected into Hela cells with another PtdIns(3)P
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Figure 1-17. Over-expressed Rubicon is localized on PtdIns(3)P enriched-structures
and this loczalization if cysteine-rich domain dependent
(a) Subcellular localization of transiently transfected Rubicon-EGFP, Rubicon(RUN)EGFP, Rubicon(C)-EGFP or Rubicon(RUNC)-EGFP in HeLa cells. In contrast to
punctate

Rubicon-EGFP

and

Rubicon(RUN)-EGFP,

Rubicon(C)-EGFP

and

Rubicon(RUNC)-EGFP were localized diffusely in the cytoplasm. Abbreviations:
RUN – RUN domain deletion, C – cysteine-rich domain deletion. Scale bars: 10 m.
(b) Local sequence alignment between the C-terminal cystein-rich domain of Rubicon
and FYVE domains of several known FYVE-containing proteins. Rubicon does not
possess the key consensus sequences of a typical FYVE domain, i.e., N-terminal WxxD,
central R[R/K]HHCR and C-terminal RVC (indicated by red bars).
(c) Co-localization of the PtdIns(3)P-enriched lipid domain marker p40 (phox)-PXEGFP (green) and Rubicon-AsRed (red) on large punctate structures (arrows) in the cotransfected HeLa cells (upper panels). Upon short treatment with 75 nM wortmannin
(another PI-3K inhibitor) for 1 hour, while the PtdIns(3)P-enriched lipid domains
disappeared, the Rubicon-AsRed-positive structures was maintained (lower panels). Scale
bars: 10 m.
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reporter, p40 (phox)-PX-EGFP, they showed extensive co-localization, suggesting that
Rubicon associated structures are enriched in Vps34/PtdIns3K product PtdIns(3)P (Fig.
17c upper panel) (Kanai et al., 2001) Therefore, although the cysteine-rich domain is
different from the typical FYVE domain and it does not directly bind to PtdIns(3)P, it is
still closely related to the function of Vps34/PtdIns3K. In order to determine if the
cysteine-rich domain dependent punctate/vesicular localization of Rubicon also depends
on Vps34/PtdIns3K function, the cells co-transfected with Rubicon-AsRed and
p40(phox)-PX-EGFP were treated with a chemical PI-3 kinase inhibitor wortmannin.
Wortmannin treatment effectively dispersed punctate localization of p40(phox)-PXEGFP, due to inhibition of Vps34/PtdIns3K activity. However the localization pattern of
Rubicon-AsRed was not affected by wortmannin treatment, suggesting that formation of
Rubicon-associated structures is not dependent on Vps34/PtdIns3K activity (Fig. 17c,
lower panel).

2.10.7 Beclin 1 is not essential for formation of Rubicon-associated structures
Although formation of the Rubicon-associated structures is not dependent on
Vps34/PtdIns3K activity, it is still closely related to it, as was indicated by colocalization of PtdIns(3)P reporter p40(phox)-PX-EGFP on these structures. It was shown
that Rubicon negatively regulated Vps34/PtdIns3K kinase activity, and that presence of
over-expressed Beclin 1 interfered with this regulatory effect. Since Rubicon was
identified as a component of the Beclin 1-Vps34/PtdIns3K protein complex, the relation
between Beclin 1 and the Rubicon associated structures was studied. First, Beclin 1AsRed was transfected into cells that stably express Rubicon-EGFP. As a result, Beclin
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Figure 1-18. Rubicon-associated structures do not have Beclin 1 on them and are
Beclin 1-independent
(a-b) Absence of full-length Beclin 1 (a) or Beclin 1-CE mutant (b) (red) on the RubiconEGFP-positive structures (green) in the HEK293 cells stably expressing Rubicon-EGFP.
These cells were transiently transfected with either Beclin 1-AsRed (a) or FLAG-Beclin
1-CE (b, i.e., the FLAG-tagged Beclin 1 mutant containing both CCD and ECD that
mediate the Beclin 1-Rubicon interaction as shown in Fig. 4c). Scale bars, 10m.
(c) The formation of the Rubicon-EGFP-positive structures was Beclin 1 independent.
HEK293 cells stably expressing Rubicon-EGFP were transfected with Beclin 1 siRNA.
Although the endogenous Beclin 1 level was significantly knocked down, as was
confirmed with western blot using Beclin 1 antibody, the formation of Rubicon-EGFP
associated structures was not affected. Scale bar, 10m.
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1-AsRed localized diffusely throughout the cytosol and no obvious co-localization of
Beclin 1-AsRed on the Rubicon-EGFP associated structures was observed (Fig. 18a).
This suggested that Beclin 1 may not be associated with the structures. To further
confirm this, coiled-coil and evolutionary conserved domains (CE) of Beclin 1 were
tagged with FLAG and transfected into Rubicon-EGFP stable cells. Previous coimmunoprecipitation experiments showed that these two domains together mediate
interaction between Beclin 1 and Rubicon (Fig. 4a&b). However, over-expressed FLAGCE showed no co-localizaiton on Rubicon-EGFP associated structures either. Finally,
endogenous Beclin 1 protein level was knocked down with RNAi in Rubicon-EGFP
stable cells to study whether Beclin 1 is required for formation of Rubicon associated
structures. After siRNA transfection, endogenous Beclin 1 level was significantly
reduced, as was confirmed with western blot. However the formation Rubicon-EGFP
associated structures was not affected and comparable numbers of Rubicon-EGFP
positive punctate and vesicular structures were observed in Beclin 1 siRNA transfected
cells and control siRNA transfected cells (Fig. 18c). In conclusion, Beclin 1 is neither
localized on Rubicon-EGFP associated structure nor required for their formation.
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Figure 1-19. A hypothetic model for the Beclin 1-Vps34/PtdIns3K protein complexes
and their functions
In this model, a core Beclin 1 complex is composed of Vps34/PI-3K, p150/Vps15, Beclin
1, UVRAG and likely substoichiometric Atg14L (indicated by the tight binding and
functional connection between Atg14L and Beclin 1). Under physiological conditions, a
large Beclin 1-Vps34 complex is formed, including the core complex and Rubicon. From
this large complex smaller functioning complexes may form such as an Atg14L-Beclin 1containing complex and a Rubicon-containing complex. These smaller complexes are
likely the functional units participating in autophagy regulation through modulating the
Vps34 lipid kinase activity.
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Chapter III
Generation and Characterization of beclin 1 Conditional Knockout
Mice

3.1 Generation of beclin 1 conditional knockout mice
The beclin 1flox/flox mice were generated using bacterial artificial chromosome (BAC)
recombination techniques in C57BL/6J strain background. The targeting BAC vector was
generated so that two loxP sequences were inserted into the genome to flank the second
exon of beclin 1 gene, where the start codon is located, and the neomycin resistant gene
pGKneo cassette with two flanking FRT sequences were inserted into the intron region
between the second and the third exons (Fig. 1a). Purified BAC DNA was electroporated
into embryonic stem (ES) cells derived from C57BL/6J-Tyrc-2J/J mice, which are in
C57BL/6J background but have white coat color due to a genetic mutation. After that
cells were treated with G418 to select the ones that express the neomycin resistant gene.
Two rounds of ES cell targeting were performed and overall 10 positive clones were
obtained from screening 100 clones with southern blot. Further southern analysis
confirmed that 8 within 10 clones were indeed positive clones in which homologous
recombination happened in the correct way, resulting in an 8% targeting efficiency.
Several positive clones were injected into C57BL/6J blastcyst, and chimera mice ranging
from 5% to 40% were obtained. Successful germ line transmission from a 30% chimera
mouse was confirmed with southern blot. After that the mice were crossed to transgenic
mice that express FLP recombinase under the control of a broad promoter
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Figure 2-1. Generation of beclin 1flox/flox mice
(a) Schematic illustration of beclin 1 gene targeting construct. A modified bacterial
artificial chromosome (BAC) clone was used as the targeting vector. Through
homologous recombination, two loxP sites (black triangles) were inserted into the
genome to flank the second axon of beclin 1, in which the start codon is located. The
neomycin resistance gene pGKneo cassette was flanked by two FRT sites (black
rectangles), and was later deleted by crossing to flipper mice. Southern blot to confirm
correct recombination was performed using a probe that is located downstream of the
homologous region B (arm B).
(b) PCR reaction and southern blot of mouse genotyping. PCR reaction was performed on
genomic DNA extracted from mouse tail clips. The primers used were located outside the
inserted loxP sites, so that a bigger-sized band was generated when the loxP sites were
successfully inserted into the genome. The southern blot was performed on BglII and
SwaI digested genomice DNA from mouse tail clips. With an extra SwaI site introduced
into the genome from homologous recombination, a shorter band was detected from the
floxed allele.
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ROSA26 (flipper mice) to remove the pGKneo cassette flanked by FRT sequences
(Fiering et al., 1993). The resulted beclin 1flox/+ mice were crossed to each other to
generate beclin 1flox/flox mice, and genotyping was performed using both polymerase chain
reaction (PCR) and southern blot (Fig. 1b). Meanwhile, beclin 1flox/+ mice were also
crossed to transgenic mice that express the Cre recombinase under the control of various
cell type specific promoters to generate beclin 1flox/+; Cre mice (Nagy, 2000). Finally
beclin 1 conditional knockout mice were generated by crossing beclin 1flox/flox mice with
beclin 1flox/+; Cre mice to delete beclin 1 expression in different cell populations.

3.2 Characterization of Beclin 1 function in Purkinje cells
3.2.1 Deletion of Beclin 1 protein in beclin 1flox/flox; Pcp2-Cre Purkinje cells
Beclin 1flox/flox mice were crossed to transgenic mice that express Cre recombinase
under the control of Purkinje cell protein 2 (Pcp2, also known as L7) promoter (Pcp2-Cre)
to delete beclin 1 expression in Purkinje cells. The Pcp2/L7 expression is restrict to
Purkinje cells in the cerebellum and bipolar neurons in the retina (Oberdick et al., 1990).
The gene expression starts from around postnatal day 2 (P2) and increases gradually to
reach its peak at P15, and the Cre recombination driven by this promoter occurs between
P15 and P19 (Nordquist et al., 1988; Komatsu et al., 2007a). To confirm that Beclin 1
protein is successfully deleted in Purkinje cells, brain sections from beclin 1flox/flox and
beclin 1flox/flox; Pcp2-Cre mice at the age of P21 were stained with anti-Beclin 1 antibody.
In beclin 1flox/flox mice, the Purkinje cells showed clear staining, while in beclin 1flox/flox ;
Pcp2-Cre mice the staining completely disappeared, indicating that Beclin 1 protein has
been successfully deleted (Fig. 2, upper panel).
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Figure 2-2. Immunohistochemistry of Beclin 1 protein expression in Purkinje cells of
beclin 1flox/flox and beclin 1flox/flox; Pcp2-Cre mice at P21
(a) Beclin 1 protein was detected in beclin 1flox/flox Purkinje cells but not in beclin 1flox/flox;
Pcp2-Cre Purkinje cells. Paraffin sections of the cerebella were stained with anti-Beclin 1
antibody and visualization was performed with DAB. Scale bar: 100 m.
(b) Floating sections from the same cerebella were stained with anti-calbindin antibody
and fluorescein conjugated secondary antibody, showing that loss of Beclin 1 protein
expression in beclin 1F/F; Pcp2-Cre Purkinje cells was not due to loss of Purkinje cells.
Scale bar: 200 m.
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3.2.2 Degeneration of beclin 1flox/flox; Pcp2-Cre Purkinje cells
To study if deletion of Beclin 1 induces any changes in Purkinje cells, sagittal
brain sections from mice at different ages were first stained with an antibody against a
Purkinje cell specific protein Calbindin. At P21, when the expression of beclin 1 has been
deleted and no protein can be detected in Purkinje cells, Calbindin staining showed no
significant difference in Purkinje cell number between beclin 1flox/flox; Pcp2-Cre mice and
beclin 1flox/flox mice (Fig. 2, lower panel). However, by the age of 1 month, the Purkinje
cell number in beclin 1flox/flox; Pcp2-Cre mice has dramatically decreased, and the
remaining Purkinje cells also showed features of severe degeneration (Fig. 3a). In order
to study whether there is area specificity in Purkinje cell degeneration, coronal cerebellar
sections were stained with anti-Calbindin antibody. At 1 month, the degeneration was
mainly in medial part of the cerebellum, where the biggest decrease in cell number was
observed. Meanwhile the number of Purkinje cells in the lateral part of the cerebellum
remained largely unchanged (Fig. 3b). By the age of 2 months, almost all of the Purkinje
cells in the medial part had disappeared (Fig. 3c).

3.2.3 Aberrant ultra-structures in early degenerating beclin 1flox/flox; Pcp2-Cre
Purkinje cells
In order to study the mechanism underlying the Purkinje cell degeneration in
beclin 1flox/flox; Pcp2-Cre mice, sections of the cerebellum were first stained with
autophagy and apoptosis markers. P62/SQSTM1 is an LC3 interaction protein that is
degraded by autophagy, and its accumulation in the cells is often viewed as a hallmark of
impaired autophagy. However when cerebellum sections from beclin 1flox/flox; Pcp2-Cre
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Figure 2-3. Degeneration of beclin 1flox/flox; Pcp2-Cre Purkinje cells
(a) Sagittal sections of cerebella from 1 month old beclin 1flox/flox and beclin 1flox/flox;
Pcp2-Cre mice were stained with anti-Calbindin antibody. Severe Purkinje cell loss was
observed in beclin 1flox/flox; Pcp2-Cre mice. Scale bar: 500 m.
(b) A coronal section of the cerebellum from a 1 month old beclin 1flox/flox; Pcp2-Cre
mouse was stained with anti-Calbindin antibody. Severity of Purkinje cell degeneration
showed area specificity. The medial region of the cerebellum showed more Purkinje cell
loss than the lateral region. Scale bar: 500 m.
(c) A sagittal section of the cerebellum from a 2 month old beclin 1flox/flox; Pcp2-Cre
mouse was stained with anti-Calbindin antibody, showing that almost all Purkinje cells
had been lost. Scale bar: 500 m.
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mice were stained with anti-p62/SQSTM1 antibody, no accumulation in the Purkinje
cells was observed (data not shown). Meanwhile, anti-activated Caspase3 antibody
staining did not detect any activated apoptosis in degenerating beclin 1flox/flox; Pcp2-Cre
Purkinje cells (data not shown).
To search for clues that can lead to possible mechanisms of degeneration of beclin
1flox/flox; Pcp2-Cre Purkinje cells, electron microscopy (EM) study was performed. To
catch the initial stage of the degeneration, a relatively early age (P21) was chosen, and
both Purkinje cell bodies and axons in the deep cerebellar nuclei region were examined
since neuronal degeneration often starts from the axon region. Semi-thin cerebellar
sections (0.5m) were first cut and stained with Toluidine Blue, and Purkinje cells that
showed darker staining than average (and therefore may be the ones undergoing early
degeneration) were chosen for further morphological study under EM. In Purkinje cell
bodies of beclin 1flox/flox; Pcp2-Cre mice, numerous electron dense structures were
observed, and similar structures were rarely detected in Purkinje cells from control beclin
1flox/flox mice. From the localization pattern, the electron dense structures could be divided
into two types. One type appeared attached to intracellular membranes although the
structures varied in size. Some were about 100nm in diameter, and were attached to Golgi
or ER like membranous structures (Fig. 4a&b, bold red arrows); some were smaller in
size and were associated with mitochondrial membranes (Fig. 4b&d, red arrowheads);
and others were sheet-like structures that extended to longer than 0.5m and were tightly
attached to mitochondrial membranes (Fig. 4a&c, red arrowheads). Interestingly, some of
these structures looked like extended tips budding off Golgi or ER membranes that
became electron dense (Fig. 4b, thin red arrow). Although most of the structures were
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Figure 2-4. Abnormal ultra-structures in degenrating beclin 1flox/flox; Pcp2-Cre
Purkinje cell bodies
P21 beclin 1flox/flox; Pcp2-Cre Purkinje cell bodies were examined with electron
microscopy, and numerous electron dense structures were observed. Some were small in
size and were associated with either Golgi-like structures (a & b, bold red arrows),
mitochondria (b, red arrowhead) or nuclear envelop (d, green arrowhead); some were in
elongated shape and were attached to mitochondria (a & c, red arrowhead); and some
looked like condensed tips of Golgi-like membranous structures (b, thin red arrows). In
addition to membrane associated small structures, organelle-resembling large structures
were also observed (b, c & d, green arrows). Meanwhile, late stage degenerating Purkinje
cells showing apoptotic features were also observed (e).
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associated with cytosolic membranes, there were also cases when some structures were
associated with the nuclear envelop (Fig. 4d, green arrowhead). In addition to these
membrane associated structures, there was another type of electron dense structures that
were much bigger in size (200nm~ in diameter) and not obviously associated with
membranes (Fig. 4b&d, green arrows). Unlike the first type, which appeared to be from
condensation of membranes, the second type of structures appeared more likely to be
accumulation of electron dense materials in intracellular organelles. In some cases,
organelles containing partially electron dense materials were observed, possibly
representing an earlier stage in formation of such structures (Fig. 4c, green arrow).
Meanwhile, Purkinje cells at late stages of degeneration were occasionally
observed under EM (Fig. 4e). The condensed cell body and nuclear resembled features of
apoptotic cell death, although staining the cerebellum sections with activated Caspase 3
antibody did not yield any positive signal (data not shown).
Abnormal structures were also observed in Purkinje cell axons in the deep
cerebellar nuclei region of the cerebellum. Purkinje cells send axons to form synapses on
deep cerebellar nuclei, and in many case axons can be the first area where degeneration is
observed. When deep cerebellar nuclei region of beclin 1flox/flox; Pcp2-Cre mice was
examined under EM, membranous structures were observed in myelinated axons and
similar structures were not detected in control mice (Fig. 5a, arrowheads). Under higher
magnification, these structures sometimes appeared to be repeatedly folded long
membranes that took either regular shape (Fig. 5b) or irregular shape (Fig. 5c), and
sometimes appeared as coated vesicles near Golgi like membranes and they resembled
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Figure 2-5. Abnormal ultra-structures in degenerating beclin 1flox/flox; Pcp2-Cre
Purkinje cell axons
The deep cerebellar nuclei region of a beclin 1flox/flox; Pcp2-Cre mouse was examined
with electron microscopy. Abnormal membranous structures were observed in
myelinated or unmyelinated axons (a, red arrowheads). The structures were regular or
irregular in shape and seemed connected to the mitochondria outer membranes (b & c,
red arrows). In some cases coated vesicles that resembled clathrin coated vesicles were
also observed (d).
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clathrin coated vesicles (Fig. 5d). In most cases, such structures were adjacent to the
mitochondria that are often observed in normal myelinated axons, and interestingly
sometimes the structures seemed to be connected to the outer membranes of the
mitochondria (Fig. 5b&c, arrows).

3.2.4 Deletion of Beclin 1 induces localization change of PtdIns(3)P in Purkinje cells
In C. elegans, deletion of beclin 1 ortholog bec-1 caused disappearance of
PtdIns(3)P, which is the product of C. elegans class III PI3-kinase LET-512/Vps34, from
cytoplasmic membranes and vesicles in larvae (Takacs-Vellai et al., 2005). To test if
deletion of beclin 1 in mice has similar effect, immuno-staining was performed on slices
of the cerebellum from P21 mice using anti-PtdIns(3)P antibody. In beclin 1flox/flox
Purkinje cells, PtdIns(3)P showed punctate localization, while in beclin 1flox/flox; Pcp2-Cre
Purkinje cells its localization became much less confined and was diffuse throughout the
whole cytoplasm. Therefore deletion of beclin 1 changed the localization pattern of
PtdIns(3)P from possibly membrane and vesicle bound to largely cytoplasmic.
In summary, deletion of Beclin 1 in Purkinje cells resulted in fast and severe cell
degeneration, although the mechanism underlying the degeneration is not clear. Staining
with autophagy and apoptosis markers showed that neither of them was activated,
therefore the Purkinje cell death may be through alternative pathways, and may be related
to altered Vps34/PtdIns3K function.
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Figure 2-6. Localization change of PtdIns(3)P in beclin 1flox/flox; Pcp2-Cre Purkinje
cells
(a) Immuno-staining with anti-PtdIns(3)P antibody showed that in beclin 1flox/flox Purkinje
cells PtdIns(3)P was localized on punctate and vesicular structures that were possibly
early endosomes and multivesicular endosomes.
(b) Anti-PtdIns(3)P antibody staining on beclin 1flox/flox; Pcp2-Cre Purkinje cells showed
that the localization of PtdIns(3)P produced was more diffuse and localized throughout
the whole cytoplasm.

97

Figure 2-6

a
F/F

b
F/F;
Pcp2
-Cre
Calbindin

PtdIns(3)P

Merge

3.3 Characterization of Beclin 1 function in cortical and hippocampal neurons
3.3.1 Beclin 1 expression is reduced in cortical and hippocampal tissues in
beclin 1flox/flox; EMX-Cre mice
Beclin 1flox/flox mice were crossed to transgenic mice that express Cre recombinase
under the control of EMX promoter (EMX-Cre) to delete beclin 1 expression in cortical
and hippocampal neurons. The expression of EMX gene and the recombination driven by
its promoter both start from early embryonic stage (Guo et al., 2000). Compared to beclin
1flox/flox mice, beclin 1flox/flox; EMX-Cre mice showed reduced body sizes from as early as
P15, and this difference persisted along development (Fig. 6a). Compared to beclin
1flox/flox mice that rarely showed early death, mortality was observed in beclin 1flox/flox;
EMX-Cre mice from the age of 6 weeks, and almost all mice died by the age of 2 months.
To confirm that Beclin 1 protein level is reduced due to deletion of the gene, the
cortex and hippocampus region of the brain was dissected out from a beclin 1flox/flox;
EMX-Cre mouse and a beclin 1flox/flox mouse at P25, and lysates were prepared. Western
blot with anti-Beclin 1 antibody showed that compared to the level in control mouse, the
Beclin 1 protein level in the beclin 1flox/flox; EMX brain lysate was significantly lower
(Fig. 6b).

3.3.2 Accumulation of p62/SQSTM1 protein in beclin 1flox/flox; EMX-Cre neurons
In cultured NIH/3T3 cells, knockdown of Beclin 1 protein level with RNAi
resulted in changes in autophagy level and accumulation of p62/SQSTM1 protein in the
cells. In order to study if loss of Beclin 1 induces the same changes in cortical and
hippocampal neurons, brain sections were first stained with anti-p62/SQSTM1 antibody.
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Figure 2-7. Reduced body size of beclin 1flox/flox; EMX-Cre mice
(a) Beclin 1flox/flox; EMX-Cre mice showed reduced body size at P15, and by 1 month, the
body size of beclin 1flox/flox; EMX-Cre is only about half of beclin 1flox/flox mice.
(b) Reduced Beclin 1 protein level in beclin 1flox/flox; EMX-Cre cerebral cortex. Lysates
from P25 beclin 1flox/flox and beclin 1flox/flox; EMX-Cre cerebral cortex tissues were used
for western blot against anti-Beclin 1 antibody. Beclin 1 protein level was significantly
lower in beclin 1flox/flox; EMX-Cre than in beclin 1flox/flox mice.
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As a result, strong accumulation of p62/SQSTM1 was observed in beclin 1flox/flox; EMXCre hippocampal pyramidal cells in CA1-CA3 area at P12 (Fig. 7a). Such accumulation
occurred in the cytosol (Fig. 7b), and was not observed in dendate gyrus neurons or in
beclin 1flox/flox mice (Fig. 7a and data not shown). This suggested that deletion of Beclin 1
in hippocampal pyramidal cells may have impaired autophagy and caused accumulation
of p62/SQSTM1 that failed to be degraded by autophagy.

Despite intracellular

accumulation of p62/SQSTM1, with anti-NeuN antibody staining, the pyramidal cells in
CA1-CA3 areas in beclin 1flox/flox; EMX-Cre mice showed comparable cell density to
beclin 1flox/flox mice at P12 (Fig. 7a). However by P15 the cell density in these areas had
greatly decreased and p62/SQSTM1 accumulation was still observed in many of the
remaining pyramidal cells (Fig. 7c).
Accumulation of p62/SQSTM1 was also observed in cortical neurons of beclin
1flox/flox; EMX-Cre mice. At P12, only scattered neurons in the pre-frontal area of the
cortex showed accumulation (Fig. 8a), and like in hippocampal pyramidal cells, the
accumulation was in the cytosol (Fig. 8b). By P15, the p62/SQSTM1 accumulation was
observed in a large number of cortical neurons, and interestingly the majority of such
neurons were within the top layers in the pre-frontal area (Fig. 8c). Similar pattern was
observed in P21 cortex as well (Fig. 8d). However, by the age of one month,
p62/SQSTM1 accumulation in the cortex had become less obvious, with only scattered
neurons showing accumulation again, and the number of such neurons further decreased
by older ages (data not shown)
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Figure 2-8. Accumulation of p62/SQSTM1 protein in beclin 1flox/flox; EMX-Cre
hippocampal pyramidal cells
(a) At P12, strong accumulation of p62/SQSTM1 protein was observed in pyramidal cells
within CA1 area of the beclin 1F/F; EMX-Cre hippocampus. Scale bar: 100m
(b) The p62/SQSTM1 protein was accumulating in the cytosol of the pyramidal cells.
Scale bar: 20m
(c) At P15, strong accumulation of p62/SQSTM1 protein still remains in beclin 1flox/flox;
EMX-Cre hippocampal pyramidal cells. The decreased density of neurons suggested the
beginning of cell loss. Scale bar: 100m
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3.3.3 Activation of Caspase3 in beclin 1flox/flox; EMX-Cre mice
By P15, the density of CA1-CA3 area hippocampal pyramidal cells have
decreased significantly in beclin 1flox/flox; EMX-Cre mice (Fig. 7c). In order to study the
possible mechanism underlying the neuronal degeneration, brain sections from beclin
1flox/flox; EMX mice were stained with antibody against activated Caspase3 to study
whether there was activation of apoptotic pathway. At P12 when there was strong
accumulation of p62/SQSTM1 in CA1 hippocampal pyramidal cells, no obvious
activated Caspase3 signal was observed in that area (data not shown). This is consistent
with the observation that the cell density in that area was comparable to control mice at
that age. At P15, when the cell density had greatly decreased, strong activated Caspase3
signal was observed in the CA1-CA3 area but not in the dentate gyrus of the
hippocampus in beclin 1flox/flox; EMX-Cre mice, or in control beclin 1flox/flox mice (Fig. 9a
and data not shown). The activation of Caspase3 reached its peak at P21, as indicated by
the massive antibody staining, and gradually decreased after that (Fig. 9b). By the age of
6 weeks, activated Caspase3 signal was still able to be observed in the hippocampus (Fig.
9c).
In contrast to hippocampus where strong activated Caspase3 signal was observed,
the signal from the cerebral cortex was much weaker and only very few cells in the cortex
showed activation of Caspase3 at P15 (Fig. 10a). By P21, the number of such cells
increased and they were mainly distributed in the upper to middle part of layer V of the
cortex (Fig. 10b). By the age of 6 weeks, Caspase3activation spread to a wider area
within the cortex: signal was also observed in layer II/III in addition to layer V (Fig. 10c).
Therefore unlike in the hippocampus of beclin 1flox/flox; EMX mice where the activation
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Figure 2-9. Accumulation of p62/SQSTM1 protein in beclin 1flox/flox; EMX-Cre
cortical neurons
(a) At P12, accumulation of p62/SQSTM1 protein was observed in scattered pyramidal
neurons within pre-frontal area of the beclin 1flox/flox; EMX-Cre cerebral cortex. Scale bar:
100m
(b) The p62/SQSTM1 protein was accumulating in the cytosol of the pyramidal neurons.
Scale bar: 20m
(c-d) At P15 (c) and P21 (d), strong accumulation of p62/SQSTM1 protein was observed
in the top layer (layer II/III) neurons of the beclin 1F/F; EMX-Cre cerebral cortex. In
deeper layers, only limited number of neurons showed p62/SQSTM1 accumulation. Scale
bar: 100m
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of apoptotic pathway peaked at P21, it gradually increased within the cerebral cortex and
showed different layer specificity at different ages.

3.3.4 Aberrant ultra-structures in degenerating beclin 1flox/flox; EMX-Cre
hippocampal pyramidal cells
To further characterize the degeneration of beclin 1flox/flox; EMX-Cre hippocampal
pyramidal cells, electron microscopy was performed. CA1 area in P12 mice was
examined because at this age there was severe accumulation of p62/SQSTM1 protein in
this area in beclin 1flox/flox; EMX-Cre cells while the overall cell density was comparable
to that in control mice. Therefore degeneration is still at early stage.
As a result, a large number of electron dense structures and aberrant membranous
structures were observed in beclin 1flox/flox; EMX-Cre hippocampal pyramidal cells but
not in control cells (Fig. 2-12). Under EM, some pyramidal cells showed severe
degeneration and reduced sizes (Fig. 2-12a, arrowheads). In these cells, large electron
dense structures were observed and they occupied almost all the remaining cytoplasmic
area of the shrinking cells (Fig. 2-12a&b, asterisks). These structures often had
concentric membranous structure next to or even connected to them (Fig. 2-12b,
arrowheads). In other cells that showed relatively normal sizes, early accumulation of
smaller electron dense structures was observed (Fig. 2-12a, area boxed in red and
enlarged in Fig. 2-12c). Accumulation possibly started from aberrant less electron dense
structures that were widespread in the cytoplasm (Fig. 2-12c&d, asterisk), and they
gradually became more electron dense and took up round shape (Fig. 2-12c, arrowheads).
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Figure 2-10. Activation of Caspase3 in beclin 1flox/flox; EMX-Cre hippocampus
(a) At P15, staining with antibody against activated caspase3 showed strong signal in
CA1 and CA3 areas of the beclin 1flox/flox; EMX-Cre hippocampus. Meanwhile, the cell
density in these areas was greatly reduced. Scale bar: 100m
(b) Stronger signal of activated caspase3 was observed at P21 in beclin 1flox/flox; EMXCre hippocampus, and cell density further decreased. Scale bar: 100m
(c) At the age of 6 weeks, massive activation of caspase3 in beclin 1flox/flox; EMX-Cre
hippocampus was still observed, although the intensity was lower compared to that at P21.
Scale bar: 100m

109

Figure 2-10

a

b

c

NeuN

Caspase3

Merge

Meanwhile, double membrane vesicles containing electron dense materials were often
observed in these cells (Fig. 2-12c, arrows). In some cells, membrane sacs that were
possibly in the process of enwrapping electron dense structures (Fig. 2-12d, arrowhead)
and newly formed double membrane vesicles (Fig. 2-12d, arrow) were observed. In some
other cells, fusion among the small electron dense structures was observed (Fig. 2-12e,
arrowheads), and continued fusion of this kind likely accompanied cell degeneration and
ultimately generated the large structures observed above (Fig. 2-12a&b, asterisks).
Furthermore, these large electron dense structures would fuse with surrounding
concentric membranous structures (Fig 2-12f, asterisk).
In summary, deletion of Beclin 1 in cortical and hippocampal pyramidal cells
resulted in intracellular accumulation of p62/SQSTM1 protein and activation of Caspase3,
suggesting that autophagy in the neurons was disrupted and apoptotic pathway was
activated. Furthermore, accumulation p62/SQSTM1 was observed and peaked at earlier
ages than activation of Caspase3, suggesting that it preceded and might have been one of
the reasons that caused activation of apoptotic pathway. A large number of electron dense
structures and abnormal membranous structures were observed in degenerating beclin
1flox/flox; EMX-Cre hippocampal pyramidal cells, suggesting that similar to the
degeneration of beclin 1flox/flox; Pcp2-Cre Purkinje cells, the degeneration of pyramidal
cells may also be related to disrupted intracellular vesicle formation or trafficking.
Interestingly, neither p62/SQSTM1 accumulation nor Caspase3 activation was detected
in beclin 1flox/flox; Pcp2-Cre Purkinje cells. Moreover, the electron dense structures
observed in Purkinje cells and in pyramidal cells were not identical. This suggests that in
response to the same Beclin 1 deletion, cerebellar Purkinje cells and hippocampal

111

Figure 2-11. Activation of Caspase3 in beclin 1flox/flox; EMX-Cre cerebral cortex
(a) At P15, only very few cells in the beclin 1flox/flox; EMX-Cre cerebral cortex showed
activated caspase3 signal. Scale bar: 100m
(b) Stronger signal of activated caspase3 was observed at P21 in beclin 1flox/flox; EMXCre cerebral cortex, and cells that showed activation of caspase3 were mainly distributed
in the middle part (layer V) of the cortex, showing layer specificity. Scale bar: 100m
(c) At the age of 6 weeks, activation of caspase3 was no longer restricted to layer V and
more cells in upper layers of the beclin 1flox/flox; EMX-Cre cerebral cortex was showing
activation of caspase3. Scale bar: 100m

112

Figure 2-11

a

b

c

NeuN

Caspase3

Merge

pyramidal cells may activate different pathways and react in different manners, although
ultimately they all end up in degeneration.
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Figure 2-12. Aberrant ultra-structures in degenerating beclin 1flox/flox; EMX-Cre
hippocampal pyramidal cells
(a) Under electron microscopy, some P12 beclin 1flox/flox; EMX-Cre hippocampal
pyramidal cells showed features of late stage degeneration (arrowheads). Large-sized
electron dense structures were observed and occupied almost all the cytoplasmic area of
these cells. The area boxed in red is enlarged in (c). Scale bar: 5m.
(b) Higher magnification image of one degenerating neuron in (a). Concentric
membranous structures (arrowheads) were observed next to and connected to the largesized electron dense structure. Scale bar: 1m.
(c) Enlarged image of the area boxed in red in (a). A large number of widespread less
electron dense structures (asterisk), many round shaped more electron denser structures
(arrowheads), and double membrane-enwrapped vesicles (arrows) were observed in the
cytoplasm of a neuron that was at a relatively early stage of degeneration. Scale bar:
500nm
(d) Another example of early stage degenerating neurons. An isolation membrane sac
was about to enwrap a small electron dense structure (arrowhead). Nearby, there was a
newly formed double membrane vesicle containing electron dense materials (arrow).
Scale bar: 500nm.
(e) Possible fusion among small electron dense structures to form the large-sized
accumulation bodies shown in (a) and (b). Scale bar: 500nm.
(f) A late stage degenerating neuron, in which the multiple-membrane structures
(arrowheads) were starting to fuse with the accumulation body (asterisk). Scale bar:
500nm.
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Chapter IV
Discussion
4.1 Identification of Beclin 1 interaction proteins
A rescued mouse was generated and used for identification of Beclin 1 interaction
proteins in this study. Under the endogenous promoter and other possible regulatory
elements that were contained in the BAC, it could be estimated that expression of beclin
1-EGFP followed loyally the expression pattern of the endogenous gene, and this was
confirmed with staining tissue sections from Beclin 1-EGFP transgenic mice (Arsov et al.,
2008). Homozygous deletion of beclin 1 gene expression is embryonic lethal and the
embryos die at around embryonic day 7.5 (E7.5). After crossing experiments, mice that
have both beclin 1 alleles deleted but the transgene beclin 1-EGFP expressed (beclin 1-/-;
beclin 1-EGFP, rescued mice) were born normally and the ratio of positive rescued pups
to controls followed the Mendel’s law. The rescued mice showed no developmental
abnormality, and further crossing experiments showed that they were also able to
reproduce normally. Therefore it could be concluded that the rescue by Beclin 1-EGFP
fusion protein was complete and the fusion protein possesses the physiological functions
of the endogenous protein.
In identifying interaction proteins, the rescued mice have several advantages over
cultured cell lines, which are often used to over-express tagged proteins with transient or
stable transfection. Over-expression of proteins in cultured cells is unphysiological, and
often results in production of proteins at levels that are extremely high compared to their
endogenous levels in vivo. As a result, the proteins produced may simply accumulate in
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the cell without functioning properly, or may even start to interact with other proteins
non-specifically. Furthermore, a certain protein may have different interaction partners in
different tissues, and using a single cell type will not be able to identify all the possible
interaction partners. In contrary to cell lines, the rescued mice provided a physiological
environment for identification of interaction proteins. The level of fusion protein
expression in the Beclin 1-EGFP transgenic mice is comparable to that of the endogenous
protein, therefore no excess of fusion protein is created and non-specific binding is
unlikely. In addition, since both endogenous beclin 1 alleles are deleted, there is no
competition between endogenous protein and the fusion protein for binding with
interaction partners. As a result, all proteins that bind to endogenous Beclin 1 can be
expected to bind to Beclin 1-EGFP instead and to be immunoprecipitated. Finally, driven
by the endogenous promoter and regulatory elements, the Beclin 1-EGFP fusion protein
is expressed ubiquitously in almost all tissue and cell types like endogenous Beclin 1. As
a result, it will be possible to use different tissues to study if any identified interaction
protein is a general one that most tissues share or is tissue-specific.
Using the rescued mice, at least six interaction proteins were identified from brain,
liver and thymus. This suggested that the identified proteins bind to Beclin 1 across
different tissue types and therefore are likely to be involved in the general regulation of
Beclin 1 function and possibly autophagy as well. Within the six proteins,
Vps34/PtdIns3K, Vps15 and UVRAG are already known Beclin 1 interaction proteins.
Vps34/PtdIns3K is the major binding partner of Beclin 1, and it was reported that all
Beclin 1 protein within the cells is associated with Vps34/PtdIns3K. Meanwhile, Vps15
is the activator essential for Vps34/PtdIns3K function and UVRAG has been shown to
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directly bind to Beclin 1. From these three proteins it could be confirmed that the in vivo
immunoprecipitation from rescued mouse tissues was successful.
Interestingly, the seven bands (six interaction proteins and the Beclin 1-EGFP
fusion protein itself) visualized with Coomassie blue staining showed different intensity.
Beclin 1-EGFP, Vps34/PtdIns3K, Vps15 and UVRAG showed comparably strong
intensity, while the intensity of Rubicon, Atg14L and Nrbf2 was much weaker. In vivo
immunoprecipitation was repeated and the same pattern was always observed (data not
shown). This suggests that the binding affinity among these proteins may be different:
Beclin 1 may have stronger or more stable binding with Vps34/PtdIns3K, Vps15 and
UVRAG than with Rubicon, Atg14L and Nrbf2. Another possibility is that the different
intensity may reflect the stoichiometry of protein complex composition: Beclin 1 may
bind to more Vps34/PtdIns3K, Vps15 and UVRAG than to Rubicon, Atg14L and Nrbf2.
Surprisingly, although Beclin 1 was first identified as a Bcl-2 interaction protein,
Bcl-2 was not identified from this study. Even western blot with Bcl-2 antibody failed to
detect any Bcl-2 in the protein mixture from the in vivo immunprecipitation (data not
shown). And the recently identified Beclin 1 interaction proteins Bif1 and Ambra1 were
not identified either. The tissue lysates used in this study for in vivo immunoprecipitation
was prepared under mild detergent condition, using Triton X100 at the final
concentration of 0.2%. Under this condition, the pellet after centrifugation that was not
used still contained a certain amount of Beclin 1 (data not shown). Therefore, it is likely
that only some insoluble membrane-bound Beclin 1 is interacting with Bcl-2 and this is
consistent with a previous report that unlike the major Beclin 1 interaction protein
Vps34/PtdIns3K that is localized predominantly on endosomes and trans Golgi network
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(Gillooly et al., 2000), Bcl-2 is localized mainly on the outer mitochondrial and ER
membranes (Germain and Shore, 2003; Pattingre et al., 2005). Interestingly it has also
been reported that full-length Beclin 1 does not interact with Bcl-2 in the yeast twohybrid system (Liang et al., 1998) and that the interaction between endogenous Beclin 1
and Bcl-2 was not detected in certain cell lines (Zeng et al., 2006). Therefore this
interaction may also be transient or unstable that only occurs under specific conditions
and therefore was not detected from in vivo immunoprecipitation in this study. The same
scenario may also be true for interaction between Beclin 1 and Bif1 or Ambra1.
Moreover, although the interaction proteins identified in this study seem to be general
ones that are shared by multiple tissues, the possibility can not be ruled out that Beclin 1
may have tissue or cell type specific binding partners. Further thorough study focusing on
specific tissues will be able to answer this question.

4.2 Beclin 1 containing protein complexes in mammalian cells
Three novel Beclin 1 interaction proteins Atg14L, Rubicon and Nrbf2 and three
already known proteins Vps34/PtdIns3K, Vps15 and UVRAG were identified in this
study. It is an interesting question how many protein complexes may exist in mammalian
cells. In yeast Atg6p forms two distinctive protein complexes with either Atg14p to
regulate autophagy, or with Vps38p to mediated CPY sorting (Kihara et al., 2001b).
However forced expression of beclin 1 in yeast strains that are deficient in atg6 only
restored autophagy but did not rescue the disrupted CPY sorting pathway (Liang 1999). It
is not due to the stable protein expressed, and this defect persisted even when Vps38p
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was over-expressed (Melendez et al., 2003). Therefore Beclin 1 may be able to
functionally interact with Atg14p but not with Vps38p.
It is not clear how many Beclin 1-containing protein complexes exist in
mammalian cells and what their composition is. In this study, endogenous
immunoprecipitation using Atg14L and Rubicon antibodies initially suggested that they
might exist in different protein complexes, since they failed to pull down each other
although they both were able to pull down Beclin 1 and Vps34/PtdIns3K. However, gel
filtration from both wild type and rescued mouse tissues showed that Beclin 1,
Vps34/PtdIns3K, Atg14L and Rubicon all eluted in the same fractions, although Atg14L
and Rubicon both eluted in later fractions as well that may represent smaller protein
complexes. This strongly suggests that all these proteins can co-exist in one same large
protein complex, and this was confirmed from transient transfection and coimmunoprecipitation experiments. Although the gel filtration experiment in this study
was not able to show distribution of UVRAG, it should be reasonable to hypothesize that
it also exists in this large complex given the fact that UVRAG and Beclin 1 bind directly
to each other (Liang et al., 2006), and this hypothesis is supported by coimmunoprecipitation as well. In addition to this large complex, it is possible that there are
multiple smaller Beclin 1-related protein complexes in mammalian cells. Some
complexes may contain only Atg14L while others may contain only Rubicon, which is
consistent with the results from endogenous immunoprecipitation using Atg14L and
Rubicon antibodies. These smaller complexes may be derived from the initial large
complex, and may be the ones that actually mediate Beclin 1’s function.

121

4.3 Beclin 1-Atg14L interaction
The protein Atg14L identified in this study showed moderate homology to yeast
protein Atg14p, and the homology was shared mainly in the coiled-coil domain region
that was shown to be essential for interaction between Beclin 1 and Atg14L. Like yeast
Atg14p, Atg14L showed strong binding affinity to Beclin 1. Upon co-transfection
Atg14L and Beclin 1 both changed intracellular localization pattern dramatically and
became co-localized with each other completely. In yeast, Atg6p and Atg14p are both
peripherally associated with membrane fractions, and pretreatment of cell extract with
detergent did not disrupt the interaction between Atg6p and Atg14p, indicating that they
are binding directly (Kametaka et al., 1998). Whether Beclin 1 and Atg14L bind to each
other directly in mammalian cells was not characterized in this study and future binding
assay using recombinant proteins will provide an answer to this question. In yeast, Atg6p
is important for the stabilization of Atg14p, because Atg14p was barely detectable in
Atg6 mutant cells (Kihara et al., 2001b). Similarly, in mammalian cells Beclin 1 is
essential for stabilization of Atg14L too, since transfection of Beclin 1 siRNA resulted in
significant decrease of Atg14L protein level. And in consistence with this, when Atg14LEGFP alone was transfected into cells, only dim fluorescence was observed, indicating
the lack of abundance of the protein in the cells. However when Beclin 1 was cotransfected, the fluorescent signal of Atg14L-EGFP became much stronger, possibly
because more protein was stabilized through forming complexes with over-expressed
Beclin 1.
Atg14L also share some functional similarity with yeast Atg14p. Atg14L
positively regulates both Vps34/PtdIns3K kinase activity and autophagy levels in the
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cells, and co-transfection of Beclin 1 and Atg14L induced electron dense structures that
were not observed in cells transfected with either Beclin 1 or Atg14L alone. Such
structures were clearly not aggresomes that arose from over-production of proteins since
they were surrounded by double membranes. Autophagy proteins that participate in
autophagosome formation such as Atg5, Atg12 and LC3 were found co-localized on
these structures, suggesting that these structures were possibly pre-autophagosomal
structures (PAS) that Atg6p and Atg14p in yeast are localized on. Therefore it is likely
that Beclin 1 and Atg14L function together to promote the initial steps of autophagosome
formation. In consistence with this, co-transfection of Beclin 1 and Atg14L induced
membrane rearrangement in the cells and increased number of autophagosomes were
observed in the transfected cells.
It is likely that Atg14L may promote autophagy levels by positively regulating
Vps34/PtdIns3K kinase activity, and Beclin 1 is essential for this since only with cotransfection of Beclin 1 did Atg14L increase the kinase activity of Vps34/PtdIns3K.
Beclin 1 increased the binding between Atg14L and Vps34/PtdIns3K, and meanwhile,
with the presence of Atg14L, Vps34/PtdIns3K was able to pull down more Beclin 1.
Therefore Beclin 1 and Atg14L enable each other to form a more stable complex with
Vps34/PtdIn3K and this complex that contains these three proteins and possibly Vps15
may be one of the smaller functioning complexes, which promotes induction of
autophagy and autophagosome biogenesis.
However to determine whether Atg14L is truly the ortholog of yeast Atg14, a
complement experiment showing that forced expression of Atg14L in Atg14 null yeast
cells can restore the autophagy level will be necessary. And if that is the case, then the

123

yeast Atg6p-Atg14p-Vps34p-Vps15p sub-complex is also well conserved from yeast to
mammalian cells like other autophagy proteins.
Treatment of Bax/Bak-/- cells with Beclin 1 siRNA also reduced Atg5-Atg12
protein levels (Shimizu et al., 2004), indicating that like Atg14L, protein stabilization of
Atg5-Atg12 may also be dependent on Beclin 1. Therefore combining the data from this
study, it can be concluded that Beclin 1 is genuinely a key protein in autophagy induction.

4.4 The functions of Rubicon
Atg6p forms a second protein complex in yeast with Vps38p, and whether
Rubicon might be its mammalian ortholog was studied. However no homology was
observed between Rubicon and Vps38p and there is very little functional similarity
between Rubicon and Vps38p. Previous studies (Kihara et al., 2001b) show that Vps38p
mediates interaction between Atg6p and Vps34p, since the interaction is disrupted in
Vps38 mutant cells. However, Rubicon is showing a rather inhibitory effect on interaction
between Beclin 1 and Vps34/PtdIns3K. Vps38p level is not detectable in Atg6 mutant
cells, indicating that Atg6p is essential for Vps38p stabilization. When Beclin 1 protein
level was knocked down with RNAi in NIH/3T3 cells, Rubicon protein level showed
little change compared to control conditions. Moreover, deletion of Vps38 in yeast
significantly reduced the PtdIns 3-kinase activity, indicating the positive regulatory
function of Vps38p. On the contrary, Rubicon negatively regulates the kinase activity of
Vps34/PtdIns3K. Therefore Rubicon is clearly not the mammalian ortholog of Vps38 and
if a mammalian ortholog does exist it still remains to be identified.
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In contrast to Atg14L, Rubicon negatively regulates autophagy, and it may also be
through its negative regulation on Vps34/PtdIns3K kinase activity. Interestingly unlike in
the case of positive regulation by Atg14L, this negative regulation is inhibited by Beclin
1, since it diminished in the presence of over-expressed Beclin 1. Meanwhile, overexpression of Rubicon decreased the amount of Vps34/PtdIns3K that Beclin 1 was able
to bind, although Beclin 1 did not interfere with the binding between Rubicon and
Vps34/PtdIns3K. Therefore Rubicon and Beclin 1 may be inhibitory on each other’s
binding to Vps34/PtdIns3K, or may be competing to bind to it in an exclusive manner.
And the inhibition of Rubicon’s negative regulation on autophagy by Beclin 1 may be
part of the functions of Beclin 1 in promoting autophagy induction. Interestingly, in cells
transiently transfected with Rubicon-EGFP, starvation induced significant increase of
binding between Rubicon-EGFP and Beclin 1. This increase of binding may be important
for starvation induced autophagy activation because it inhibits the negative regulation by
Rubicon on Vps34/PtdIns3K and therefore results in a positive regulation.
Over-expression of Rubicon resulted in massive abnormal vesicle structures that
were labeled positive for late endosome/early lysosome marker LAMP1 and multivesicular body marker LBPA, suggesting that Rubicon is likely to be involved in
endocytic pathway in addition to its function in autophagy regulation. To test whether
endocytosis is affected by over-expression or protein knock-down of Rubicon, horse
radish peroxidase (HRP) intake and epidermal growth factor (EGF) induced receptor
(EGFR) internalization was examined in cells transfected with either Rubicon-EGFP or
Rubicon siRNA. In both cases, no significant difference was observed between Rubicon
transfected cells and control cells. Therefore the internalization step of endocytosis
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appears not significantly affected by Rubicon, and this is consistent with the observation
that only a small number of Rubicon induced structures were positive for early endosome
marker EEA1. Rubicon blocks autophagosome maturation, and the reason can be either
that the fusion step of autophagosomes with lysosomes is inhibited, or that lysosomes
themselves fail to develop normally. Therefore, the involvement of Rubicon in endocytic
pathway may also be at a relatively late stage, such as maturation of endosomes and their
fusion with lysosomes.
The functions of Rubicon in endocytic pathway may also be closely related to
Vps34/PtdIns3K. Although the C-terminal cysteine-rich domain of Rubicon is not
identical to the FYVE domain and does not bind directly to PtdIns(3)P, the product of
Vps34/PtdIns3K, nevertheless they showed extensive co-localization. It is likely that
Vps34/PtdIns3K binds to Rubicon and is localized on the Rubicon-associated structures,
and therefore its product is enriched where Rubicon is localized. However co-transfection
experiments showed that Beclin 1 is not co-localized on the Rubicon-associated
structures. A previous report showed that knocking down Beclin 1 protein level in cells
did not affect the endocytic pathway (Zeng et al., 2006). Moreover, in mammalian cells,
quantitative analyses with a cross-linker showed that although all Beclin 1 is associated
with Vps34/PtdIns3K complex, ~50% of Vps34/PtdIns3K is free of Beclin 1. And partial
overlap between Vps34/PtdIns3K and late endosome/mutli-vesicular body (MVB)
marker LBPA is observed (Kihara et al., 2001a). Therefore a small Rubicon functioning
complex that contains Vps34/PtdIns3K but not Beclin 1 may exist on the Rubiconassociated structures.
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Both immunoprecipitation from wild type cells using anti-Rubicon antibody and
immunoprecipitation from Rubicon-EGFP stable cells using GFP antibody showed that
UVRAG binds to Rubicon but not to Atg14L. This suggested that UVRAG may be in the
smaller functioning complex with Rubicon although anti-UVRAG antibody failed to
detect clear signal from fractions collected from gel filtration. Interestingly, UVRAG has
been shown to be closely related to autophagosome maturation and endocytic trafficking
as well (Liang et al., 2008) However in that study, both endogenous and epitope-tagged
UVRAG consistently showed colocalization with early endosomal marker EEA1 but not
with late endosomal markers. Moreover, UVRAG was shown to facilitate autophagosome
maturation and fusion of endosomes with lysosomes through its interaction with class C
Vps complex, and Beclin 1 was not necessary for that function. Therefore Rubicon and
UVRAG seem to function at similar steps of the same pathways, but in directly opposite
directions. However this does not argue against the possibility that Rubicon and UVRAG
may co-exist in the small functioning complex: their opposite functions may be important
for keeping autophagy and endocytosis levels well balanced and under control in the cells.
From the data of this study, a model can be proposed. There is a large Beclin 1
protein complex that contains at least most of the Beclin 1 interaction proteins identified
in this study: Vps34/PtdIns3K, Vps15, UVRAG, Atg14L and Rubicon. Within this large
complex, Beclin 1, Vps34/PtdIns3K, Vps15 and UVRAG may be the core component
given their similar stoechiometry as identified from the in vivo immunoprecipitation.
Although Atg14L was detected at a much lower intensity, from its high binding affinity
with Beclin 1, it is possible that Atg14L is also one of the core components. Multiple
smaller protein complexes can be generated from this initial large complex and may be

127

the ones that actually function in various cellular pathways. One such complex contains
Beclin 1, Vps34/PtdIns3K and Atg14L, and it functions at the initial step of autophagy
and promotes antuphagosome biogenesis. Another complex contains Vps34/PtdIns3K
and Rubicon, and may contain UVRAG as well but not Beclin 1. Its function is in
inhibiting endocytic pathway and autophagosome maturation (Fig. 1-19). Through
interaction with either Atg14L or Rubicon, Beclin 1 may be playing a critical role in
regulating the balance of autophagy and thereby in maintaining the homeostasis of the
cells.

4.5 Function of Beclin 1 in autophagy and development
Specific deletion of beclin 1 in several populations of neurons caused
degeneration, and different cell types showed different phenotypes. In cortical and
hippocampal pyramidal cells, deletion of beclin 1 induced intracellular accumulation of
p62/SQSTM1, indicating that autophagy in these neurons was disrupted. Activation of
apoptotic pathway and massive cell death were also observed. Interestingly,
p62/SQSTM1 accumulation preceded the activation of apoptotic pathway and cell death
by a few days, suggesting that the failure to degrade intracellular proteins might have
been one of the reasons that induced apoptosis activation. It is also consistent with
previous reports that deletion of Atg5 or Atg7 in the central nervous system induced
inhibition of basal level of autophagy and caused accumulation of ubiquitinated proteins
and activation of apoptosis (Hara et al., 2006; Komatsu et al., 2006).
Electron microscopy studies revealed accumulation of electron dense structures in
beclin 1-/-; EMX-Cre hippocampal pyramidal cells. The accumulation likely starts from
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protein aggregates that fail to be degraded by autophagy, and gradually include aberrant
membrane structures that are generated possibly also due to disruption of autophagy. The
degeneration of the cells proceeds as the accumulation bodies grow, and at the late stages
of degeneration, the accumulation bodies will likely occupy almost all the cytoplasmic
area. Interestingly, a large number of double membrane vesicles that resembled
autophagosomes were observed in beclin 1-/-; EMX-Cre hippocampal pyramidal cells,
suggesting that the deletion of beclin 1 may not inhibit autophagosome formation but
rather may block the clearance of autophagosomes. And this is consistent with the
observation that knocking down Beclin 1 protein level in NIH/3T3 cells increased LC3II
form level. Furthermore, it is also consistent with the functional interaction between
Beclin 1 and its newly identified interaction protein Rubicon. Since Rubicon blocks
autophagosome maturation and this activity may be inhibited by Beclin 1, deletion of
beclin 1 may result in an increase in blocking of autophagosome maturation. Although
studies have shown that Beclin 1 is essential for autophagy, its exact function is still
unclear. Therefore further in vivo characterization of autophagy pathway in beclin 1-/-;
EMX-Cre hippocampal pyramidal cells will provide important information.
In contrast to cortical and hippocampal pyramidal cells, when beclin 1 was
deleted in Purkinje cells, despite severe degeneration and massive cell loss, no obvious
p62/SQSTM1 accumulation and activation of apoptosis was observed. Instead Purkinje
cells at early stage of degeneration showed many electron dense structures that from their
morphology seemed closely related to the intracellular membranes. Since Beclin 1 is part
of the Vps34/PtdIns3K complex and the complex has important functions in membrane
trafficking in the cells, it can be speculated that the phenotype induced by deletion of
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beclin 1 may be related to Vps34/PtdIns3K function. In yeast, Atg6p is not essential for
activation of Vps34p, since Atg6 mutant cells showed only a slight decrease in PtdIns 3kinase activity (~80% of wild type cells) (Kihara et al., 2001b). Similarly siRNA
mediated knockdown of Beclin 1 in NIH/3T3 cells did not significantly affect the
Vps34/PtdIns3K kinase activity in the cells (data not shown). Therefore, it is likely that
Beclin 1 does not catalytically regulate Vps34/PtdIns3K activity but rather mediates its
intracellular localization, possibly by selectively forming different small functioning
protein complexes. Therefore deletion of beclin 1 in Purkinje cells may have induced
aberrant localization of Vps34/PtdIns3K. Since Vps34/PtdIns3K has important function
in membrane trafficking and lysosomal enzyme sorting, its mislocalization can result in
defect in membrane genesis and lysosome development in the cells. Immuno-staining
with anti-PtdIns(3)P antibody showed that deletion of beclin 1 induced changes in
localization of PtdIns(3)P, the product of Vps34/PtdIns(3)K, in Purkinje cells. Future
electron microscopy experiments using PtdIns(3)P probes such as tagged 2xFYVE
domains will be performed to confirm the specific localization of PtdIns(3)P in both
control and beclin 1-/-; Pcp-2 Cre Purkinje cells. Meanwhile, immuno-staining studies
using lysosomal markers will be performed to examine whether there is abnormality in
lysosome development and maturation in beclin 1-/-; Pcp-2 Cre Purkinje cells.
Comparing the phenotypes of beclin 1 neuronal knockout mice and Atg5/Atg7
neuronal knockout mice, some big differences can be immediately noticed. Atg7flox/flox;
nextin-Cre mice can live as long as 28 weeks (Komatsu et al., 2004), while almost all
beclin 1flox/flox; EMX-Cre mice, though with much more limited cell populations affected,
die by 8 weeks. Atg7flox/flox; Pcp2-Cre mice don’t show severe Purkinje cell death until

130

P56 while in beclin 1flox/flox; Pcp2-Cre mice Purkinje cell degeneration starts from as early
as P21 and by the age of one month almost half of the Purkinje cells are dead (Komatsu
et al., 2007a). Similar difference exists between beclin 1-/- and Atg5-/-/Atg7-/- mice. Both
Atg5-/- and Atg7-/- mice survive to be born while beclin 1-/- die at early developmental
stage at E7.5 (Yue et al., 2003; Kuma et al., 2004; Komatsu et al., 2005). Therefore it is
suggested that Beclin 1 has other critical function than just regulating autophagy and
therefore is more important for development than other autophagy proteins. The results
from this study suggest that Beclin 1 may also regulate membrane trafficking and
lysosome development in the cells, possibly through interaction with Vps34/PtdIns(3)K.
Future study focusing on this direction will likely provide useful information to help
better understand the functions of Beclin 1.
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Methods and materials
Reagents and antibodies
Dynabeads M-270 epoxy, NuPAGE Bis-Tris gels, Western blot transfer buffer,
MES SDS running buffer, antioxidant, Lipofectamine 2000 and Lipofectamine RNAi
MAX kits were purchased from Invitrogen (Carlsbad, CA). Modified Trypsin, EDTAfree protease inhibitor cocktail tablets, and FuGene 6 transfection reagent were purchased
from Roche Diagnostics (Indianapolis, IN). Immobilon-P PVDF membrane was
purchased from Millipore (Billerica, MA). GelCode Blue Stain Reagent, Trifluoroacetic
acid, Tris(2-carboxyethyl)-phosphine hydrochloride, and the Micro BCA Protein Assay
Reagent Kit were purchased from Pierce (Rockford, IL). Gel filtration calibrant mixtures
were purchased from BioRad (Hercules, CA). Phosphatidylinositol was purchased from
Avanti Polar Lipids (Alabaster, AL). Radio-active

32

P-ATP was purchased from

PerkinElmer (Waltham, MA). G418, anti-myc affinity gel beads, 3,3'-Diaminobenzidine
(DAB) and urea tablets were purchased from Sigma (St Louis, MO). Beclin 1 siRNA was
purchanse from Dharmacon (Lafayette, CO); Atg14L siRNA was purchased from
Invitrogen (Carlsbad, CA); and Rubicon and control siRNA were purchased from
Ambion (Austin, TX). Coated silica gel was purchased from EMD (Gibbstown, NJ).
Fluorescence mounting medium was purchased from Abcam (Cambridge, MA).
Vectastain Elite ABC kit was purchased from Vector Laboratories (Burlingame, CA).
Commercial antibodies used in this study include rabbit polyclonal LC3 antibody
(1:1000, MBL, Woburn, MA), rabbit polyclonal antibody raised against the C-terminal of
UVRAG (1:500, Abgent, San Diego, CA), rabbit polyclonal Beclin 1 antibody (1:600;
Santa Cruz Biotechnology, Santa Cruz, CA), guinea pig polyclonal p62/SQSTM1
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antibody (1:1000, American Research Products, Inc., Belmont, MA), mouse monoclonal
Lamp 1 antibody (1:10, Developmental Studies Hybridoma Bank at the University of
Iowa, Iowa City, IA), mouse monoclonal LBPA antibody (1:200, Echelon Biosciences
Inc. Salt Lake City, UT), rabbit polyclonal Vps34antibody (1:250, Zymed Laboratories,
San Francisco, CA), mouse monoclonal syntaxin 6 antibody (1:600, BD Tranduction
Laboratories, , San Jose, CA), mouse monoclonal EEA1 antibody (1:600, BD
Tranduction Laboratories, San Jose, CA), mouse monoclonal protein disulphide
isomerase (PDI) antibody (1:100, Abcam, Cambridge, MA), mouse monoclonal c-myc
antibody (1:1000; Santa Cruz Biotechnology, Inc., Santa Cruz, CA; Zymed Laboratories,
San Francisco, CA), mouse monoclonal M2 FLAG and -actin antibodies (Sigma, St.
Louis, MO), anti-rabbit Alexa Fluo 555 and Alexa 488 (1:1000, Invitrogen, Carlsbad,
CA), Rhodomine red conjugated secondary antibody (Jackson ImmunoResearch, West
Grove, PA), anti-mouse and anti-rabbit Cy5 (1:500, Zymed Laboratories, San Francisco,
CA), rabbit IgG (1:6000; Amersham, Pittsburgh, PA), mouse IgG (1:10000; Pierce,
Rockford, IL).
Rabbit polyclonal GFP antibody was raised against GST-tagged GFP and affinity
purified in house as described previously (Cristea et al., 2005). Rabbit polyclonal Atg14L
and Rubicon antibodies were generated as described below. Full length cDNA of Atg14L
was cloned into NdeI and BamHI sites of bacterial expression vector pET-28a(+)
(Novagen, USA). Partial cDNA of Rubicon that corresponds to amino acids 220-941 was
cloned into NheI and BamHI sites of pET-28a(+) vector. Recombinant 6 His-tagged
Atg14L and Rubicon proteins were expressed in BL21-Codon-Plus (DE3)-RIL
competent cells and purified with Ni-NTA agarose beads (Qiagen, USA). A total of 500
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g of purified recombinant protein was used for injections to produce polyclonal
antibodies in rabbits (Cocalico Biologicals, Inc. Reamstown, PA). Sera were either
purified with protein-G column (GE Healthcare, Piscataway, NJ) (Rubicon) or further
affinity purified with recombinant protein (Atg14L).

Generation and genotyping of the Beclin1-EGFP BAC transgenic mice
Beclin1-EGFP mice were generated using BAC mouse transgenic techniques
(Gong et al., 2002). In brief, a 455-base pair homology region immediately upstream of
stop codon of Becn1 gene (“A box”) was PCR amplified and inserted between AscI and
SmaI sites of pLD53.SCA-E-B, and another 507-base pair homology region immediately
downstream of stop codon was PCR amplified and inserted between PacI and StuI sites
of the vector (“B box”) (Gong et al., 2002). Through homologous recombination, DNA
sequence encoding EGFP protein followed by a stop codon was inserted into the BAC
clone RP24-392C4 which contains all regulatory elements of Beclin 1 gene to replace the
original stop codon of Beclin 1. The modified BAC clone was purified using CsCl
gradient ultra-centrifugation, and used for pronuclear injection in FVB/NJ mice. All mice
were backcrossed to C57BL/6J background for more than 10 generations before analysis.
Genotype of mice from pronuclear injection was determined with either southern
blot or PCR reaction. For southern blot, a 0.5 inch piece of mouse tail was clipped from
the tail end and incubated in lysis buffer (27% sucrose, 1 SSC, 1 mM EDTA, 1% SDS,
200 g/ml proteinase K) at 55°C overnight. After extractions with phenol:chloroform
(1:1) and with chloroform, DNA was precipitated with ethanol and dissolved in TE buffer.
Genomic DNA was digested with XhoI and XbaI, and was analyzed with southern blot
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using “A box” as the hybridization probe. For PCR reaction, the EGFP forward and
reverse primer pairs are:
Forward: CCTACGGCGTGCAGTGCTTCAGC
Reverse: CGGCGAGCTGCACGCTGCCGTCCTC

Generation of rescued mice
Beclin 1-EGFP/+ transgenic mice were genetically crossed with beclin 1 +/– mice
to generate rescued mice, in which both endogenous beclin 1 alleles are deleted and only
beclin 1-EGFP transgene is expressed. First, beclin 1-EGFP mice were crossed with
beclin 1

+/–

mice to obtain beclin 1 +/–; beclin 1-EGFP mice. Then mice of this genotype

were further crossed with beclin 1

+/–

mice to obtain beclin 1

–/–

; beclin 1-EGFP mice.

Tails were clipped from mice and protein was extracted in protein lysis buffer (20mM
HEPES, pH7.4/ 1mM MgCl2/0.25mM mM CaCl2/ 0.2% Triton X-100/150mM NaCl/
protease inhibitor and PMSF-pepstatin/DNaseI), after which western blot with antiBeclin 1 antibody was performed to confirm the deletion of endogenous Beclin1 protein.
Multiple litters were produced and the numbers of mice of each genotype were counted to
examine whether the Mendel’s law was followed.

Affinity purification and mass spectrometric analysis
Affinity purification of Beclin 1 interacting proteins and mass spectrometric
identification of these proteins were carried out as described (Wang et al., 2006), with
slight modification. In brief, tissue extracts were obtained from both Becn1+/– and Becn1–
/–

; Becn1-EGFP mice (4 months of age) by homogenizing 2 brains or 1 liver with a
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motor-driven homogenizer (speed 2.5, 12 strokes) in 4 ml buffer containing 0.32 M
sucrose, 1 mM NaHCO3, 20 mM HEPEs/pH 7.4, 1 mM MgCl2, 0.25 mM CaCl2, PIC,
200 g/mL PMSF, pepstatin 4 g/mL and DNase I. The tissue extracts were centrifuge at
1,400 g for 10 min and the pellets were homogenized again in 4 ml buffer for 8 strokes
and centrifuged again. Supernatants from the two homogenization steps were pooled,
centrifuged at 750 g for 10 min. Aliquots of the resulting supernatants were used for gel
filtration experiments. The remaining supernatants were diluted with equal volumes of 2
pull-out buffer and then 2 volumes of 1 pull-out buffer containing 20 mM HEPEs/pH
7.4, 1 mM MgCl2, PIC, 100 g/mL PMSF, 2 g/mL pepstatin, 0.2% triton X-100 and
150 mM NaCl. Each sample was incubated with 5 mg M-270 Epoxy Dyanbeads, which
were pre-coated with affinity purified polyclonal anti-GFP antibody, for 1.5 hours at 4C.
Dynabeads were washed 5 times with 1 pull-out buffer and then incubated with 250 l
elution buffer containing 0.5 mM EDTA and 0.5 M NH3·H2O for 20 min at room
temperature. The eluents were collected, frozen in liquid nitrogen and dried in a
Speedvac. The purified complexes were resolved on SDS-PAGE and stained with
colloidal Coomassie. The entire gel lane of the Becn1–/–-; Becn1-EGFP/+ sample was
sliced into ~30 2-mm wide pieces. Each gel piece was reduced, alkylated with
iodoacetamide, and subject to in-gel digestion with trypsin. The resulting tryptic peptides
were analyzed by MS and MS/MS, using either in-house-constructed MALDI-QqTOF
and MALDI-ion trap (LCQ DECA XP; Thermo Electron Corporation) mass
spectrometers or ESI-LTQ mass spectrometer (Thermo Electron Corporation). Accurate
masses of the tryptic peptides and the masses of their product ions were used to identify
proteins in each gel piece, using the computer search engines ProFound
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(http://prowl.rockefeller.edu/prowl-cgi/profound.exe), Xproteo (http://www.xproteo.com)
and GPM (http://prowl.rockefeller.edu/tandem/thegpm_tandem.html) to search the most
up-to-date NCBI non-redundant mouse protein database.

Plasmid constructs and stable cell lines
Total RNA was extracted from postnatal day 12 mouse whole brain using RNeasy
mini kit (Qiagen, USA). Full length cDNA was synthesized with Omniscript RT kit
(Qiagen, USA) and used as templates for PCR amplifications with KOD HiFi DNA
polymerase (Novagen, USA). Beclin1 was cloned into EcoRI and BamHI sites of
pEGFP-N3 and pAs-Red vectors (Clonetech, USA). Atg14L was cloned into EcoRI and
BamHI sites of pEGFP-N3, pAsRed and pCMV-FLAG (Sigma, St Louis, MO) vectors.
Rubicon was cloned into HindIII and BamHI sites of pEGFP-N3, pAs-Red and pCMVFLAG2 vectors. UVRAG was cloned into XhoI and BamHI sites of pEGFP-N3 vector.
Single or combinations of Beclin1 domains were cloned into EcoRI and BamHI sites of
pCMV-FLAG2 vector. Truncated Atg14L mutants were cloned into EcoRI and BamHI
sites of pEGFP-N3 vector. Truncated Rubicon mutants were cloned into KpnI and
BamHI sites of pEGFP-N3 vector. EGFP-Atg12 and EGFP-Atg5 constructs were
generously provided by Dr. X. Jiang. Myc-hVps34-hVps15-V5-His/pVITRO2 plasmid
was described previously (Yan et al., 2008).

Cell cultures and transfections
Human embryonic kidney (HEK) 293 and 293T, Hela and NIH/3T3 cells were
maintained in standard medium, i.e., Dulbecco’s modified Eagle’s medium (DMEM)
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supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin
(Invitrogen, Carlsbad, CA). MLE12 cells were generously provided by Dr. C Münz and
maintained in DMEM/F12 medium (ATCC, Manassas, VA) supplemented with 0.005
mg/ml insulin, 0.01 mg/ml transferrin, 30 nM sodium selenite, 10 nM hydrocortisone, 10
nM beta-estradiol, 10 mM HEPEs, 2 mM L-glutamine, 2% FBS and 1% penicillinstreptomycin. Transient DNA transfection was performed with standard calcium
phosphate precipitation procedure, FuGene 6 or Lipofectamine 2000 kit, following the
protocols provided by the manufacturers (Invitrogen, Carlsbad, CA). siRNA transfection
of NIH/3T3 cells and GFP-LC3 MLE12 stable cells was performed with Lipofectamine
RNAi MAX kit following the reverse transfection protocol provided by the manufacturer.
The sequences of siRNAs are:
Beclin 1: CAGUUUGGCACAAUCAAUA
Atg14L: UUUGCGUUCAGUUUCCUCACUGCGC
Rubicon: GCCUUCAGUCUAUGCCACA

Generation of stable cell lines
HEK293 cells were transfected with pEGFP-N3 vector, Beclin 1-EGFP, Atg14LEGFP or Rubicon-EGFP, and were selected with 800 g/ml G418 for one week. Single
colonies with EGFP expression were picked and culture was continued in medium
supplemented with 200g/ml G418. Correct expression of EGFP-fusion protein was
confirmed with western blot using anti-GFP antibody, after which cells were maintained
in culture medium supplemented with 200g/ml G418.
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In vitro protein immunoprecipitation (IP)
DNA plasmids were transfected into HEK293T cells for IP. For Co-IP
experiments, two or three plasmids were transfected simultaneously in equal amount.
Cells were lysed in IP lysis buffer (20mM HEPES, pH7.4/ 1mM MgCl2/0.25mM mM
CaCl2/

0.2%

Triton

X-100/150mM

NaCl/

protease

inhibitor

and

PMSF-

pepstatin/DNaseI). For IP with anti-GFP, anti-Atg14L or anti-Rubicon antibody,
Dynabeads M-270 E-proxy (Invitrogen, Carlsbad, CA) were conjugated with each
antibody, and incubated with cell lysate at 4°C for 2 hours. After the beads were washed
in IP lysis buffer for 5 times, proteins were eluted by incubating beads in elution buffer
(0.5mM EDTA, pH8/0.5N NH3H2O) at room temperature for 20 minutes and dried with
vacuum speed centrifuge. For FLAG-tagged protein IP, Anti-FLAG M2 affinity resin
(Sigma, St Louis, MO) was used and the manufacture’s protocol was followed.

Vps34kinase assay
Vps34kinase assay was performed as described (Miled et al., 2007). MychVps34-hVps15-V5-His/pVITRO2 plasmid was transfected into HEK293T cells in
combination with other FLAG-tagged or EGFP-tagged plasmids. Cells were lysed in 1%
Nonidet P-40 lysis buffer (20 mM Tris/pH 7.5, supplemented with 137 mM NaCl, 1 mM
MgC12, 1 mM CaC12, 100 mM NaF, 10 mM sodium pyrophosphate, 100 M Na3VO4,
10% glycerol, and 0.35 mg/ml phenylmethylsulfonyl fluoride/protease and phosphatase
inhibitors). Immunoprecipitation was performed with anti-myc affinity gel beads (Sigma,
St Louis, MO), following manufacture’s protocol. Beads were washed in lysis buffer
three times, followed by three washes in washing buffer (100 mM Tris-HCl/pH7.4 and
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500 mM LiCl) and two washes in reaction buffer (10 mM Tri-HCl/pH7.4, 100 mM NaCl
and 1 mM EDTA). Beads were re-suspended in 60 l of reaction buffer, followed by
addition of 10 1 of 100 mM MnCl2 and 10 l of sonicated phosphatidylinositol (2
g/l). The reaction was started by the addition of 10 l of 440 M ATP containing 10
Ci of -32P-ATP, and beads were incubated for 10 min at room temperature. Reaction
was terminated by adding 20l 8 M HCl, and organic phase was extracted with 160l
chloroform:methanol (1:1). Extracted phospholipids products were resolved by thin layer
chromatography (TLC) using a coated silica gel and a solvent composed of
chloroform:methanol:H2O:ammonium hydroxide (v/v/v/v, 9:7:1.7:0.3), followed by
visualization with Typhoon 9400 Variable Imager (GE Healthcare Biosciences,
Piscataway, NJ).

Immuno-staining
Cultured cells were fixed in fresh 4% paraformaldihyde in 1x PBS, and
permeablized in PBS with either 0.05%-0.1% Triton X-100 or 0.01% saponin for 10-30
min at room temperature. After blocking in PBS containing 10% goat serum for 30 min-1
h at room temperature, cells were incubated in primary antibodies overnight at 4°C. After
three washes in PBS, cells were incubated with fluorescent secondary antibodies for one
hour at room temperature, followed by four washes in PBS. Cells were mounted with
fluorescence mounting medium and examined under Zeiss (Göttingen, Germany) upright
and invert confocal microscopes.
Brain sections were permeabilized in blocking buffer (10% goat serum and 0.1%
Triton X-100 in PBS), and were incubated in primary antibodies diluted in blocking

140

buffer overnight at 4°C. Sections were then washed in PBS and incubated in Alexa Fluor
conjugated secondary antibodies (Invitrogen) in PBS for 1 hour at room temperature.
After washes in PBS, sections were mounted and examined in the same way as above.
For HRP staining with paraffin sections, antigen retrieval was first performed and
sections were incubated in 0.5% H2O2 for 15 minutes at room temperature to block the
endogenous peroxidase activity. After permeabilization in the same blocking buffer as
above, sections were incubated in primary antibodies diluted in blocking buffer overnight
at 4°C. Vectastain Elite ABC Kit (Vector Laboratories) was used for secondary antibody
reaction and signal detection following the manufacturer’s protocol.

Electron microscopy
For morphology EM, transfected HEK293T cells were fixed in 2.5%
glutaraldehyde (2.5GA) in 0.1M cacodylate buffer, pH 7.4. Animals were perfusion
fixed with 2% paraformaldehyde and 2% glutaraldehyde in 0.1M PB (pH7.4), and 200m
sections were cut with vibrotme. After sample processing and embedding, 0.5 mm thin
sections were cut and stained with 1% Toluidine Blue, and areas for further examination
were selected under light microscope. Samples were then processed by routine
transmission electron microscopy procedure and embedded in Epon (Yue et al., 2002).
For immuno-EM, transfected HEK293T cells were fixed in fresh PLP fixative
(4% paraformaldehyde, 0.01M periodate, 0.075M lysine, and 0.075M phosphate
buffer/pH7.4) supplemented with 0.05% glutaraldehyde for one hour. After three washes
in PBS, cells were permeabilized with 0.01% saponin in PBS supplemented with 0.1%
BSA for 15 minutes at room temperature, and were incubated with primary antibody
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(anti-GFP) diluted in the same buffer overnight at 4°C. Vectastain Elite ABC kit was
used for secondary antibody reaction, and cells were fixed again in 1.5% glutaraldehyde
in 0.1 M cacodylate buffer supplemented with 5% sucrose. After three washes with 50
mM Tris/pH 7.4 supplemented with 7.5% sucrose, DAB reaction was performed with the
same kit. The reaction was stopped with 50 mM Tris/pH 7.4 supplemented with 7.5%
sucrose, and cells were processed for silver enhancement as described (TeclemariamMesbah et al., 1997).
Sample blocks were cut with a diamond knife on a Leica UltracutE and ultra-thin
(~70 nm) sections were collected on uncoated 200-mesh grids and stained with Uranium
and Lead. Grids were viewed with a TecnaiSpiritBT Transmissiiom Electron Microscope
(FEI) at 80 KV and pictures were taken with Gatan 895 ULTRASCAN Digital Camera.
Image levels were processed in Adobe Photoshop (Adobe Systems, San Jose, CA) to
enhance contrast.

Gel Filtration
Liver and brain extracts from both beclin 1

+/–

and beclin 1

–/–

; beclin 1-GFP/+

mice at 4 month of age were prepared as described above. Cell extracts were prepared as
previously described (Wang et al., 2006). Tissue and cell extracts were diluted with
equal volumes of 2 pull-out buffer (see above) and incubated for 15 min at 4C. The
samples were then subject to ultracentrifugation at 100,000 g and the resulting
supernatants were used for gel filtration experiments. Superdex 200 HR10/30 column
(Pharmacia) was equilibrated with 2 bed volumes of filtered running buffer containing 20
mM HEPEs/pH 7.4, 1 mM MgCl2, 500 g/mL PMSF, 1 g/mL pepstatin and 150 mM
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NaCl. The column was calibrated using Biorad gel filtration calibrant mixture, which are
composed of thyroglobulin (670 kDa), -globulin (158 kDa), ovalbumin (44 kDa),
myoglobin (17 kDa) and vitamin B12 (1,350 Da). A spike of these calibrants (10 l) was
also added to each sample (240 l) as internal calibrants. Both calibrants and samples
were run at a flow rate of 0.2 ml/min. For each run, 2 bed volumes of buffer were used to
elute the sample and a total of 80 fractions were collected 25-29 min after starting the
runs and at a rate of 1 fraction/min. Two bed volumes of buffer were used to wash the
column at the same flow rate in between two runs.

Long-lived protein degradation assay
Long-lived protein degradation was accessed as described (Gronostajski and
Pardee, 1984). In brief, NIH/3T3 cells were transfected with either control or Atg14L
siRNA and plated in 12-well plates. After 48 h, standard medium was changed to leucinefree medium supplemented with 1 Ci/ml 3H-L-leucine. After being pulse-labeled for 24
h, cells were washed 3 times and further cultured in standard medium supplemented with
excess unlabeled leucine (5 mM) for 16 h to chase out short-lived proteins. Cells were
then washed 3 times and further cultured for 4 h in standard medium, Earle’s Balanced
Salt Solution (EBSS), or EBSS supplemented with 10 mM 3-MA, all containing 5 mM
unlabeled leucine. Both media and cell lysate were subject to trichloroacetic acid (TCA)
precipitation. Long-lived protein degradation was calculated as the ratio of TCA-soluble
medium radioactivity to TCA-precipitated cell lysate radioactivity.
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Construction of beclin 1 targeting vector
Two shuttle vectors were used to generate the final vector for BAC modification.
S351 contains the diphtheria toxin A-fragment gene (DT-A) for negative selection at
gene targeting against random integration, and S385 contains the two loxP sites and the
pGKneo cassette flanked by two FRT sites. An DNA fragment about 1000 base pair (bp)
in size (box A1), starting from around 1060 bp upstream of start codon of beclin 1 gene
to around 60 bp upstream of start codon, was PCR amplified using BAC DNA as
template and inserted into AscI and EcoRV sites of S351. A DNA fragment about 500 bp
(box A2) immediately downstream of box A1 (and containing the second exon of beclin
1 gene) was PCR amplified and inserted into EcoRV and KpnI sites of S385. A third
DNA fragment about 2000 bp (box B) immediately downstream of box A2 was
subcloned into FseI and SmaI sites of S351 and was later used as short arm for
homologous recombination in gene targeting. Another DNA fragment about 2000 bp
(box C) downstream of box B was subcloned into XbaI site of S351, and was used for
homologous recombination in the process of BAC modification. Finally all the elements
in S385 were linearized with NotI and PmeI digestion and ligated into NotI and SwaI
sites of S351, generating the complete shuttle vector for BAC modification. Through
modification, the loxP-A2-FRT-pGKneo-FRT-loxP fragment was replaced into the BAC
clone. After linearization with PI-SceI digestion, the BAC clone was used as the targeting
vector for gene targeting.
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Gene targeting and blastocyst injection
Linearized targeting vector was electroporated into embryonic stem (ES) cells
derived from C57BL/6J-Tyrc-2J/J mice, and selection was performed with G418 treatment.
50 surviving clones were picked and genomic DNA was extracted, followed by digestion
with BamHI. Southern blot was performed using a 500 bp DNA fragment downstream of
box B (short arm of the targeting vector) as the probe. Clones that gave a 5700 bp band
were picked as possible positive clones, while negative clones gave a 4000 bp band.
Genomic DNA from selected positive clones was purified and digested with SwaI and
BglII, and southern blot was performed with the same probe as above. Clones that gave a
band of 5500 bp were confirmed to be true positive clones from correct homologous
recombination, and were used for blastocyst injection. For southern blot, genomic DNA
was digested with restriction enzymes and separated on agarose gels, followed by transfer
to nylon membrane (NP0HYB0010, GE). Probe synthesis and hybridization was
performed using Prime-It II random primer labeling kit (Stratagene), following the
manufacturer’s manual.

Mouse genotyping
Chimera mice from blastocyst injection were crossed to wild type C57BL/6J mice,
and pups with white coat color were tail clipped for genotyping. Genomic DNA was
extracted as described above and was used for southern blot. For genotyping analyses
starting from F2 generation, the following primers were used.
Forward: 5’-CCACCACCAAGGCAGCGGGTAG-3’
Reverse: 5’-TCACTGATGGCTCTAACCTCAACTCGTC-3’
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Generation of conditional knockout mice
Positive mice were first crossed to transgenic mice that express FLP recombinase
under the control of a broad promoter ROSA26 to remove the PGK-neo cassette flanked
by two FRT sites from the genome, and the deletion was confirmed with southern blot.
For genotyping FLP mice, the following primers were used
Forward: 5’-CTAATGTTGTGGGAAATTGGAGC-3’
Reverse: 5’-CTCGAGGATAACTTGTTTATTGC-3’
Beclin 1flox/+ mice were crossed to each other to generate beclin 1flox/flox mice.
Meanwhile they were crossed with either Pcp2-Cre or EMX-Cre mice to generate beclin
1flox/+; Cre/+ mice. Finally beclin 1flox/flox mice were crossed with beclin 1flox/+; Cre/+ mice
to generate beclin 1flox/flox; Cre/+ mice, in which beclin 1 expression is specifically
deleted in either cerebellar Purkinje cells (Pcp2-Cre) or cortical and hippocampal
pyramidal cells (EMX-Cre). For genotyping Cre mice, the following primers were used.
Forward: 5’-CCGGTGAACGTGCAAAACAGGCTCTA-3’
Reverse: 3’-CTTCCAGGGCGCGAGTTGATAGC-3’

Preparation of brain slices
Mice at different ages were put into anesthesia with intraperitoneal Nembutal
injection at dose of 0.01ml/g body weight. Perfusion was performed with 4%
paraformaldehyde in 0.1M phosphate buffer (pH7.4), and dissected brains were post
fixed in the same fixative at 4°C for overnight. For floating sections, brains were
embedded into 5% low melting agarose gel and 40m sections were cut with vibrotome
(Vibrotome). For cryosections, brains were subjected to cryo-protection in 30% sucrose
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at 4°C for overnight, and then were embedded into Neg-50 compound (Richard-Allan
Scientific). 20m sections were cut with cryostat (Leica). For paraffin sections, brains
were dehydrated in series of ethanol (70%, 80%, 90%, and 100%) for 30 minutes x 2,
followed by incubation in Xylene for 3 days, and were embedded into wax. 10m
sections were cut with a microtome (Leica).
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